Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jan Verhoef

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Physiology

Anatomy

Procedures

Microbial Sensitivity Tests

Chemicals & Drugs

Disorders

Geographic Areas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bloemendaal A L A; Fluit A C; Jansen W T M; Vriens M R; Ferry T; Amorim J M; Pascual A; Stefani S; Papaparaskevas J; Borel Rinkes I H M; Verhoef J
Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units.
Paauw Armand; Caspers Martien P M; Leverstein-van Hall Maurine A; Schuren Frank H J; Montijn Roy C; Verhoef Jan; Fluit Ad C
Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.
Ikawaty Risma; Brouwer E C; Jansen M D; van Duijkeren E; Mevius D; Verhoef J; Fluit A C
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jan Verhoef (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bloemendaal A L A; Fluit A C; Jansen W T M; Vriens M R; Ferry T; Amorim J M; Pascual A; Stefani S; Papaparaskevas J; Borel Rinkes I H M; Verhoef J
Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(9):918-20.
2009: Paauw Armand; Caspers Martien P M; Leverstein-van Hall Maurine A; Schuren Frank H J; Montijn Roy C; Verhoef Jan; Fluit Ad C
Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.
Microbiology (Reading, England) 2009;155(Pt 5):1478-88.
2009: Ikawaty Risma; Brouwer E C; Jansen M D; van Duijkeren E; Mevius D; Verhoef J; Fluit A C
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis.
Veterinary microbiology 2009;136(3-4):277-84.
2009: Bloemendaal Alexander L A; Fluit Ad C; Jansen Wouter M T; Vriens Menno R; Ferry Tristan; Argaud Laurent; Amorim Jose M; Resende A C; Pascual Alvaro; López-Cerero Lorena; Stefani Stefania; Castiglione Giacomo; Evangelopoulou Penelope; Tsiplakou Sophia; Rinkes Inne H M Borel; Verhoef Jan
Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(2):117-24.
2009: van Asbeck E C; Hoepelman A I M; Scharringa J; Verhoef J
The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis.
International journal of antimicrobial agents 2009;33(1):21-6.
2008: Jansen W T M; Verel A; Beitsma M; Verhoef J; Milatovic D
Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.
Current medical research and opinion 2008;24(10):2853-61.
2008: Ikawaty Risma; Willems Rob J L; Box Adrienne T A; Verhoef Jan; Fluit Ad C
Novel multiple-locus variable-number tandem-repeat analysis method for rapid molecular typing of human Staphylococcus aureus.
Journal of clinical microbiology 2008;46(9):3147-51.
2008: Jansen W T M; Verel A; Verhoef J; Milatovic D
In vitro activity of AR-709 against Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2008;52(3):1182-3.
2008: Ridwan B U; Koning C J M; Besselink M G H; Timmerman H M; Brouwer E C; Verhoef J; Gooszen H G; Akkermans L M A
Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis.
Letters in applied microbiology 2008;46(1):61-7.
2008: van Asbeck Eveline C; Hoepelman Andy I M; Scharringa Jelle; Herpers Bjorn L; Verhoef Jan
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.
BMC microbiology 2008;8():229.
2008: Paauw Armand; Caspers Martien P M; Schuren Frank H J; Leverstein-van Hall Maurine A; Delétoile Alexis; Montijn Roy C; Verhoef Jan; Fluit Ad C
Genomic diversity within the Enterobacter cloacae complex.
PloS one 2008;3(8):e3018.
2007: Jansen W T M; Verel A; Verhoef J; Milatovic D
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Antimicrobial agents and chemotherapy 2007;51(9):3420-4.
2007: Vlaminckx Bart J M; Schuren Frank H J; Montijn Roy C; Caspers Martien P M; Beitsma M M; Wannet Wim J B; Schouls Leo M; Verhoef Jan; Jansen Wouter T M
Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996.
Infection and immunity 2007;75(7):3673-9.
2007: Ekkelenkamp Miquel B; Verhoef Jan; Bonten Marc J
Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1457-9.
2007: Vlaminckx Bart J M; Schuren Frank H J; Montijn Roy C; Caspers Martien P M; Fluit Ad C; Wannet Wim J B; Schouls Leo M; Verhoef Jan; Jansen Wouter T M
Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray.
Infection and immunity 2007;75(5):2603-11.
2007: Paauw Armand; Verhoef Jan; Fluit Ad C; Blok Hetty E M; Hopmans Titia E M; Troelstra Annet; Leverstein-van Hall Maurine A
Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures.
Journal of clinical microbiology 2007;45(5):1420-5.
2007: Amidi Maryam; Romeijn Stefan G; Verhoef J Coos; Junginger Hans E; Bungener Laura; Huckriede Anke; Crommelin Daan J A; Jiskoot Wim
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Vaccine 2007;25(1):144-53.
2006: Jansen W T M; Verel A; Beitsma M; Verhoef J; Milatovic D
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae.
The Journal of antimicrobial chemotherapy 2006;58(4):873-7.
2006: Jansen W T M; van der Bruggen J T; Verhoef J; Fluit A C
Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2006;9(3):123-33.
2006: Jansen W T M; Beitsma M M; Koeman C J; van Wamel W J B; Verhoef J; Fluit A C
Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2006;50(6):2072-8.
2006: Paauw Armand; Fluit Ad C; Verhoef Jan; Leverstein-van Hall Maurine A
Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital.
Emerging infectious diseases 2006;12(5):807-12.
2006: Fluit A C; van der Bruggen J T; Aarestrup F M; Verhoef J; Jansen W T M
Priorities for antibiotic resistance surveillance in Europe.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(5):410-7.
2006: Mascini E M; Troelstra A; Beitsma M; Blok H E M; Jalink K P; Hopmans T E M; Fluit A C; Hene R J; Willems R J L; Verhoef J; Bonten M J M
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(6):739-46.
2006: Verhoef Jan; Fluit Ad
Surveillance uncovers the smoking gun for resistance emergence.
Biochemical pharmacology 2006;71(7):1036-41.
2006: Leverstein-van Hall Maurine A; Blok Hetty E M; Paauw Armand; Fluit Ad C; Troelstra Annet; Mascini Ellen M; Bonten Marc J M; Verhoef Jan
Extensive hospital-wide spread of a multidrug-resistant enterobacter cloacae clone, with late detection due to a variable antibiogram and frequent patient transfer.
Journal of clinical microbiology 2006;44(2):518-24.
2006: Andriesse Gunnar I; Verhoef Jan
Nosocomial pneumonia : rationalizing the approach to empirical therapy.
Treatments in respiratory medicine 2006;5(1):11-30.
2005: Baudner Barbara C; Verhoef J Coos; Giuliani Marzia M; Peppoloni Samuele; Rappuoli Rino; Del Giudice Giuseppe; Junginger Hans E
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.
Journal of drug targeting 2005;13(8-9):489-98.
2005: in 't Veen Joke P M; van den Berg Mascha P; Romeijn Stefan G; Verhoef J Coos; Merkus Frans W H M
Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;61(1-2):27-31.
2005: Diancourt Laure; Passet Virginie; Verhoef Jan; Grimont Patrick A D; Brisse Sylvain
Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.
Journal of clinical microbiology 2005;43(8):4178-82.
2005: Borges Olga; Borchard Gerrit; Verhoef J Coos; de Sousa Adriano; Junginger Hans E
Preparation of coated nanoparticles for a new mucosal vaccine delivery system.
International journal of pharmaceutics 2005;299(1-2):155-66.
2005: Vriens Menno R; Blok Hetty E M; Gigengack-Baars Ada C M; Mascini Ellen M; van der Werken Chris; Verhoef Jan; Troelstra Annet
Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(7):629-33.
2005: Fluit A C; Florijn A; Verhoef J; Milatovic D
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.
The Journal of antimicrobial chemotherapy 2005;56(1):133-8.
2005: Fluit Ad C; Florijn Alice; Verhoef Jan; Milatovic Dana
Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
Antimicrobial agents and chemotherapy 2005;49(4):1636-8.
2005: van Leeuwen H J; Van Der Tol M; Van Strijp J A G; Verhoef J; van Kessel K P M
The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
Clinical and experimental immunology 2005;140(1):65-72.
2005: Ekkelenkamp Miquel B; Hanssen Micha; Danny Hsu Shang-Te; de Jong Ad; Milatovic Dana; Verhoef Jan; van Nuland Nico A J
Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
FEBS letters 2005;579(9):1917-22.
2005: Carretto E; Barbarini D; Couto I; De Vitis D; Marone P; Verhoef J; De Lencastre H; Brisse S
Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(3):177-84.
2005: van Loon Harald J; Vriens Menno R; Fluit Ad C; Troelstra Annet; van der Werken Christiaan; Verhoef Jan; Bonten Marc J M
Antibiotic rotation and development of gram-negative antibiotic resistance.
American journal of respiratory and critical care medicine 2005;171(5):480-7.
2005: Box Adrienne T A; Mevius Dik J; Schellen Pepijn; Verhoef Jan; Fluit Ad C
Integrons in Escherichia coli from food-producing animals in The Netherlands.
Microbial drug resistance (Larchmont, N.Y.) 2005;11(1):53-7.
2004: Nijssen S; Florijn A; Bonten M J M; Schmitz F J; Verhoef J; Fluit A C
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
International journal of antimicrobial agents 2004;24(6):585-91.
2004: Tsukayama D T; van Loon H J; Cartwright C; Chmielewski B; Fluit A C; van der Werken Chr; Verhoef J;
The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
International journal of antimicrobial agents 2004;24(4):339-45.
2004: Brisse S; van Himbergen T; Kusters K; Verhoef J
Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(10):942-5.
2004: Dorkoosh F A; Stokkel M P M; Blok D; Borchard G; Rafiee-Tehrani M; Verhoef J C; Junginger H E
Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphy.
Journal of controlled release : official journal of the Controlled Release Society 2004;99(2):199-206.
2004: van der Merwe S M; Verhoef J C; Verheijden J H M; Kotzé A F; Junginger H E
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(2):225-35.
2004: van Loon H J; Box A T A; Verhoef J; Fluit A C
Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
International journal of antimicrobial agents 2004;24(2):130-4.
2004: Fluit Ad C; Schmitz Franz-Joseph; Verhoef Jan; Milatovic Dana
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
International journal of antimicrobial agents 2004;24(1):59-66.
2004: Haeggman S; Löfdahl S; Paauw A; Verhoef J; Brisse S
Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 2004;48(7):2400-8.
2004: van den Berg Mascha P; Verhoef J Coos; Romeijn Stefan G; Merkus Frans W H M
Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):131-5.
2004: Vlaminckx B; van Pelt W; Schouls L; van Silfhout A; Elzenaar C; Mascini E; Verhoef J; Schellekens J
Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(6):434-44.
2004: van den Berg Mascha P; Merkus Paul; Romeijn Stefan G; Verhoef J Coos; Merkus Frans W H M
Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.
Pharmaceutical research 2004;21(5):799-802.
2004: Antal-Szalmás Péter; Poppelier Miriam J J G; Sümegi Andrea; van der Bruggen Tjomme; Verhoef Jan; van Kessel Kok P M; van Strijp Jos A G
Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
Immunology letters 2004;93(1):11-5.
2004: van Dessel Helke; Dijkshoorn Lenie; van der Reijden Tanny; Bakker Nancy; Paauw Armand; van den Broek Peterhans; Verhoef Jan; Brisse Sylvain
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.
Research in microbiology 2004;155(2):105-12.
2004: Fluit Ad C; Schmitz Franz-Josef; Verhoef Jan; Milatovic Dana
In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.
Antimicrobial agents and chemotherapy 2004;48(3):1007-11.
2004: Baudner Barbara C; Morandi Maurizio; Giuliani Marzia M; Verhoef J Coos; Junginger Hans E; Costantino Paolo; Rappuoli Rino; Del Giudice Giuseppe
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.
The Journal of infectious diseases 2004;189(5):828-32.
2004: Dorkoosh Farid A; Broekhuizen Corine A N; Borchard Gerrit; Rafiee-Tehrani Morteza; Verhoef J Coos; Junginger Hans E
Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers.
Journal of pharmaceutical sciences 2004;93(3):743-52.
2004: Jonas Daniel; Spitzmüller Bettina; Daschner Franz D; Verhoef Jan; Brisse Sylvain
Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Research in microbiology 2004;155(1):17-23.
2004: van der Merwe S M; Verhoef J C; Kotzé A F; Junginger H E
N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):85-91.
2004: Polnok A; Borchard G; Verhoef J C; Sarisuta N; Junginger H E
Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):77-83.
2004: Polnok Assadang; Verhoef J Coos; Borchard Gerrit; Sarisuta Narong; Junginger Hans E
In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels.
International journal of pharmaceutics 2004;269(2):303-10.
2003: Wu Ya Ping; Wei Ran; Verhoef Jan
Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids.
BMJ (Clinical research ed.) 2003;327(7428):1405.
2003: Mascini E M; Jalink K P; Kamp-Hopmans T E M; Blok H E M; Verhoef J; Bonten M J M; Troelstra A
Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.
Journal of clinical microbiology 2003;41(12):5377-83.
2003: Nijssen Saskia; Bonten Marc J M; Franklin Cory; Verhoef Jan; Hoepelman Andy I M; Weinstein Robert A
Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit.
Archives of internal medicine 2003;163(22):2785-6.
2003: Vlaminckx Bart J M; Mascini Ellen M; Schellekens Joop; Schouls Leo M; Paauw Armand; Fluit Ad C; Novak Rodger; Verhoef Jan; Schmitz Franz Josef
Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants.
Journal of clinical microbiology 2003;41(11):4941-9.
2003: Blok Hetty E M; Troelstra Annet; Kamp-Hopmans Titia E M; Gigengack-Baars Ada C M; Vandenbroucke-Grauls Christina M J E; Weersink Annemarie J L; Verhoef Jan; Mascini Ellen M
Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(9):679-85.
2003: Baudner Barbara C; Giuliani Marzia M; Verhoef J Coos; Rappuoli Rino; Junginger Hans E; Giudice Giuseppe Del
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.
Vaccine 2003;21(25-26):3837-44.
2003: van Westreenen Mireille; Paauw Armand; Fluit Ad C; Brisse Sylvain; van Dijk Willemien; Verhoef Jan
Occurrence and spread of SHV extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Curacao.
The Journal of antimicrobial chemotherapy 2003;52(3):530-2.
2003: Kamp-Hopmans Titia E M; Blok Hetty E M; Troelstra Annet; Gigengack-Baars Ada C M; Weersink Annemarie J L; Vandenbroucke-Grauls Christina M J E; Verhoef Jan; Mascini Ellen M
Surveillance for hospital-acquired infections on surgical wards in a Dutch university hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(8):584-90.
2003: Van den Berg Mascha P; Merkus Paul; Romeijn Stefan G; Verhoef J Coos; Merkus Frans W H M
Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.
Journal of drug targeting 2003;11(6):325-31.
2003: Verhoef Jan; Gillissen A
Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime.
International journal of antimicrobial agents 2003;21(6):501-9.
2003: van Leeuwen Henk J; Heezius Eric C J M; Dallinga Geesje M; van Strijp Jos A G; Verhoef Jan; van Kessel Kok P M
Lipoprotein metabolism in patients with severe sepsis.
Critical care medicine 2003;31(5):1359-66.
2003: Pereira Cândida F; Paridaen Judith T M L; Rutten Karla; Huigen Marleen C D G; van de Bovenkamp Marja; Middel Jeena; Beerens Nancy; Berkhout Ben; Schuurman Rob; Marnett Lawrence J; Verhoef Jan; Nottet Hans S L M
Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication.
Antiviral research 2003;58(3):253-63.
2003: Higgins P G; Fluit A C; Milatovic D; Verhoef J; Schmitz F-J
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa.
International journal of antimicrobial agents 2003;21(5):409-13.
2003: Pereira Cândida F; Paridaen Judith T M L; van de Bovenkamp Marja; Middel Jeena; Verhoef Jan; Nottet Hans S L M
APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
The Journal of antimicrobial chemotherapy 2003;51(5):1181-9.
2003: Fluit A C; Florijn A; Verhoef J; Schmitz F-J
High-level gentamicin resistance in Enterococcus faecium and Enterococcus faecalis blood culture isolates from 23 European university hospitals.
International journal of antimicrobial agents 2003;21(4):357-9.
2003: Leverstein-van Hall Maurine A; M Blok Hetty E; T Donders A Rogier; Paauw Armand; Fluit Ad C; Verhoef Jan
Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin.
The Journal of infectious diseases 2003;187(2):251-9.
2003: Milatovic D; Schmitz F-J; Verhoef J; Fluit A C
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.
Antimicrobial agents and chemotherapy 2003;47(1):400-4.
2003: van Kessel Kok; Veldkamp Karin Ellen; Pesschel Andreas; de Haas Carla; Verhoef Jan; van Strijp Jos
Tips and tricks from Staphylococcus aureus.
Advances in experimental medicine and biology 2003;531():341-9.
2003: Verhoef Jan
Antibiotic resistance: the pandemic.
Advances in experimental medicine and biology 2003;531():301-13.
2002: Troelstra A; Kamp-Hopmans T E M; Wessels F J M; Bilkert-Mooiman M A J; Verhoef J; Mascini E M
[Epidemic of methicillin-resistant Staphylococcus aureus due to the transfer of 2 Dutch burn patients from a hospital outside of the Netherlands; who suffers the consequences?]
Nederlands tijdschrift voor geneeskunde 2002;146(46):2204-7.
2002: Vriens M; Blok H; Fluit A; Troelstra A; Van Der Werken C; Verhoef J
Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(11):782-6.
2002: Wielders C L C; Fluit A C; Brisse S; Verhoef J; Schmitz F J
mecA gene is widely disseminated in Staphylococcus aureus population.
Journal of clinical microbiology 2002;40(11):3970-5.
2002: Dorkoosh F A; Verhoef J C; Borchard G; Rafiee-Tehrani M; Verheijden J H M; Junginger H E
Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers.
International journal of pharmaceutics 2002;247(1-2):47-55.
2002: Dorkoosh Farid A; Verhoef J Coos; Verheijden Jos H M; Rafiee-Tehrani Morteza; Borchard Gerrit; Junginger Hans E
Peroral absorption of octreotide in pigs formulated in delivery systems on the basis of superporous hydrogel polymers.
Pharmaceutical research 2002;19(10):1532-6.
2002: Leverstein-van Hall Maurine A; Fluit Ad C; Paauw Armand; Box Adrienne T A; Brisse Sylvain; Verhoef Jan
Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
Journal of clinical microbiology 2002;40(10):3703-11.
2002: van der Lubben I M; van Opdorp F A C; Hengeveld M R; Onderwater J J M; Koerten H K; Verhoef J C; Borchard G; Junginger H E
Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
Journal of drug targeting 2002;10(6):449-56.
2002: Vriens Menno R; Fluit Ad C; Troelstra Annet; Verhoef Jan; van der Werken Chris
Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(9):491-4.
2002: Higgins P G; Fluit A C; Hafner D; Verhoef J; Schmitz F-J
Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates.
The Journal of antimicrobial chemotherapy 2002;50(3):438-40.
2002: Rey Luis C; Wolf Bart; Moreira J Luciano B; Milatovic Dana; Verhoef Jan; Farhat Calil K
Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.
International journal of antimicrobial agents 2002;20(2):86-92.
2002: Higgins P G; Fluit A C; Milatovic D; Verhoef J; Schmitz F-J
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 2002;50(2):299-301.
2002: Milatovic Dana; Schmitz Franz-Josef; Verhoef Jan; Fluit Ad C
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
The Journal of antimicrobial chemotherapy 2002;50(2):293-9.
2002: Fluit A C; Schmitz F-J; Verhoef J; Milatovic D
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
The Journal of antimicrobial chemotherapy 2002;50(2):271-6.
2002: Leverstein-Van Hall M A; Paauw A; Box A T A; Blok H E M; Verhoef J; Fluit A C
Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital.
Journal of clinical microbiology 2002;40(8):3038-40.
2002: Schmitz F-J; Schwarz S; Milatovic D; Verhoef J; Fluit A C
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
The Journal of antimicrobial chemotherapy 2002;50(1):145-8.
2002: Leverstein-van Hall Maurine A; Box Adrienne T A; Blok Hetty E M; Paauw Armand; Fluit Ad C; Verhoef Jan
Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting.
The Journal of infectious diseases 2002;186(1):49-56.
2002: Dorkoosh Farid A; Setyaningsih Dewi; Borchard Gerrit; Rafiee-Tehrani Morteza; Verhoef J Coos; Junginger Hans E
Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers.
International journal of pharmaceutics 2002;241(1):35-45.
2002: Fluit Ad C; Verhoef Jan; Schmitz Franz-Josef;
Antimicrobial resistance among isolates cultured from patients hospitalized with lower respiratory tract infection in Europe.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002;6(2):144-6.
2002: Beaujean D; Veltkamp S; Blok H; Gigengack-Baars A; van der Werken C; Verhoef J; Weersink A
Comparison of two surveillance methods for detecting nosocomial infections in surgical patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(6):444-8.
2002: van Dessel H; Kamp-Hopmans T E M; Fluit A C; Brisse S; de Smet A M G A; Dijkshoorn L; Troelstra A; Verhoef J; Mascini E M
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit.
The Journal of hospital infection 2002;51(2):89-95.
2002: Smits Hessel A; Rijsmus Annemarie; van Loon Joyce H; Wat Jesse W Y; Verhoef Jan; Boven Leonie A; Nottet Hans S L M
Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes.
Journal of neuroimmunology 2002;127(1-2):160-8.
2002: Brisse Sylvain; Fussing Vivian; Ridwan Ben; Verhoef Jan; Willems Rob J L
Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates.
Journal of clinical microbiology 2002;40(6):1977-84.
2002: Brisse Sylvain; Stefani Stefania; Verhoef Jan; Van Belkum Alex; Vandamme Peter; Goessens Wil
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.
Journal of clinical microbiology 2002;40(5):1743-8.
2002: van den Berg Mascha P; Romeijn Stefan G; Verhoef J Coos; Merkus Frans W H M
Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.
Journal of neuroscience methods 2002;116(1):99-107.
2002: Schmitz Franz-Josef; Beeck Andreas; Perdikouli Mirella; Boos Mechthild; Mayer Susanne; Scheuring Sybille; Köhrer Karl; Verhoef Jan; Fluit Ad C
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
Journal of clinical microbiology 2002;40(4):1546-8.
2002: Rey Luís C; Wolf Bart; Moreira J Luciano B; Verhoef Jan; Farhat Calil K
[Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility]
Jornal de pediatria 2002;78(2):105-12.
2002: Florijn A; Nijssen S; Schmitz F-J; Verhoef J; Fluit A C
Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(3):241-3.
2002: Ridwan Ben; Mascini Ellen; van Der Reijden Netty; Verhoef Jan; Bonten Marc
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?
BMJ (Clinical research ed.) 2002;324(7338):666-8.
2002: Dorkoosh Farid A; Borchard Gerrit; Rafiee-Tehrani Morteza; Verhoef J Coos; Junginger Hans E
Evaluation of superporous hydrogel (SPH) and SPH composite in porcine intestine ex-vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(2):161-6.
2002: Schmitz Franz-Josef; Petridou Jasmina; Milatovic Dana; Verhoef Jan; Fluit Ad C; Schwarz Stefan
In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.
The Journal of antimicrobial chemotherapy 2002;49(3):580-2.
2002: Schmitz F-J; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit A C
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
The Journal of antimicrobial chemotherapy 2002;49(1):220-3.
2002: Borst Annemarie; Verhoef Jan; Boel Edwin; Fluit Ad C
Clinical evaluation of a NASBA-based assay for detection of Candida spp. in blood and blood cultures.
Clinical laboratory 2002;48(9-10):487-92.
2001: Schmitz F J; Perdikouli M; Beeck A; Verhoef J; Fluit A C;
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
The Journal of antimicrobial chemotherapy 2001;48(6):935-6.
2001: Schmitz F J; Verhoef J; Milatovic D; Fluit A C
Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(11):827-9.
2001: Leverstein-van Hall M A; Fluit A C; Blok H E; Box A T; Peters E D; Weersink A J; Verhoef J
Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(11):785-91.
2001: Thanou M; Verhoef J C; Nihot M T; Verheijden J H; Junginger H E
Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P.
Pharmaceutical research 2001;18(11):1638-41.
2001: van der Lubben I M; Verhoef J C; Borchard G; Junginger H E
Chitosan for mucosal vaccination.
Advanced drug delivery reviews 2001;52(2):139-44.
2001: Thanou M; Verhoef J C; Junginger H E
Oral drug absorption enhancement by chitosan and its derivatives.
Advanced drug delivery reviews 2001;52(2):117-26.
2001: Schmitz F J; Perdikouli M; Beeck A; Verhoef J; Fluit A C
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates.
International journal of antimicrobial agents 2001;18(5):433-6.
2001: Mascini E M; Jansze M; Schouls L M; Verhoef J; Van Dijk H
Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
International journal of antimicrobial agents 2001;18(4):395-8.
2001: van der Lubben I M; Verhoef J C; Borchard G; Junginger H E
Chitosan and its derivatives in mucosal drug and vaccine delivery.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;14(3):201-7.
2001: Thanou M; Verhoef J C; Junginger H E
Chitosan and its derivatives as intestinal absorption enhancers.
Advanced drug delivery reviews 2001;50 Suppl 1():S91-101.
2001: Fluit A C; Wielders C L; Verhoef J; Schmitz F J
Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study.
Journal of clinical microbiology 2001;39(10):3727-32.
2001: Schmitz F J; Hafner D; Geisel R; Follmann P; Kirschke C; Verhoef J; Köhrer K; Fluit A C
Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital.
Journal of clinical microbiology 2001;39(10):3724-6.
2001: Peters E D; Leverstein-van Hall M A; Box A T; Verhoef J; Fluit A C
Novel gene cassettes and integrons.
Antimicrobial agents and chemotherapy 2001;45(10):2961-4.
2001: Fluit A C; Verhoef J; Schmitz F J;
Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(9):617-25.
2001: van Leeuwen H J; van Beek A P; Dallinga-Thie G M; van Strijp J A; Verhoef J; van Kessel K P
The role of high density lipoprotein in sepsis.
The Netherlands journal of medicine 2001;59(3):102-10.
2001: Schmitz F J; Boos M; Mayer S; Hafner D; Jagusch H; Verhoef J; Fluit A C
Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2001;45(9):2666-7.
2001: Brisse S; Verhoef J; Tibayrenc M
Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages.
International journal for parasitology 2001;31(11):1218-26.
2001: Fluit A C; Schmitz F J; Verhoef J;
Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens.
International journal of antimicrobial agents 2001;18(2):147-60.
2001: Verhoef J
Stopping short the spread of methicillin-resistant Staphylococcus aureus.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;165(1):31-2.
2001: Schmitz F J; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit A C
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2001;48(1):148-52.
2001: Thanou M; Verhoef J C; Verheijden J H; Junginger H E
Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Pharmaceutical research 2001;18(6):823-8.
2001: Smits H A; van Beelen A J; de Vos N M; Rijsmus A; van der Bruggen T; Verhoef J; van Muiswinkel F L; Nottet H S
Activation of human macrophages by amyloid-beta is attenuated by astrocytes.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(11):6869-76.
2001: Wielders C L; Vriens M R; Brisse S; de Graaf-Miltenburg L A; Troelstra A; Fleer A; Schmitz F J; Verhoef J; Fluit A C
In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected].
Lancet 2001;357(9269):1674-5.
2001: Brisse S; Verhoef J
Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping.
International journal of systematic and evolutionary microbiology 2001;51(Pt 3):915-24.
2001: Schmitz F J; Petridou J; Astfalk N; Scheuring S; Köhrer K; Verhoef J; Fluit A C; Schwarz S
Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(5):1603-4.
2001: Pfaller M A; Acar J; Jones R N; Verhoef J; Turnidge J; Sader H S
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S156-67.
2001: Gales A C; Jones R N; Forward K R; Liñares J; Sader H S; Verhoef J
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S104-13.
2001: Merkus P; Romeijn S G; Verhoef J C; Merkus F W; Schouwenburg P F
Classification of cilio-inhibiting effects of nasal drugs.
The Laryngoscope 2001;111(4 Pt 1):595-602.
2001: Dorkoosh F A; Verhoef J C; Borchard G; Rafiee-Tehrani M; Junginger H E
Development and characterization of a novel peroral peptide drug delivery system.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(3):307-18.
2001: Pereira C F; Middel J; Jansen G; Verhoef J; Nottet H S
Enhanced expression of fractalkine in HIV-1 associated dementia.
Journal of neuroimmunology 2001;115(1-2):168-75.
2001: Smits H A; de Vos N M; Wat J W; van der Bruggen T; Verhoef J; Nottet H S
Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages.
Journal of neuroimmunology 2001;115(1-2):144-51.
2001: van der Lubben I M; Verhoef J C; van Aelst A C; Borchard G; Junginger H E
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
Biomaterials 2001;22(7):687-94.
2001: Fluit A C; Schmitz F J; Verhoef J;
Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(3):188-91.
2001: Borst A; Leverstein-Van Hall M A; Verhoef J; Fluit A C
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA).
Diagnostic microbiology and infectious disease 2001;39(3):155-60.
2001: Beaujean D; Blok H; Gigengack-Baars A; Kamp-Hopmans T; Ballemans K; Verhoef J; Weersink A
Five-year surveillance of patients with communicable diseases nursed in isolation.
The Journal of hospital infection 2001;47(3):210-7.
2001: Jansen W T; Väkeväinen-Anttila M; Käyhty H; Nahm M; Bakker N; Verhoef J; Snippe H; Verheul A F
Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.
Clinical and diagnostic laboratory immunology 2001;8(2):245-50.
2001: Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit A C; Schmitz F J
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(3):938-42.
2001: Jansen W T; Hogenboom S; Thijssen M J; Kamerling J P; Vliegenthart J F; Verhoef J; Snippe H; Verheul A F
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Infection and immunity 2001;69(2):787-93.
2001: Schmitz F J; Krey A; Sadurski R; Verhoef J; Milatovic D; Fluit A C;
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates.
The Journal of antimicrobial chemotherapy 2001;47(2):239-40.
2001: Thanou M; Nihot M T; Jansen M; Verhoef J C; Junginger H E
Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Journal of pharmaceutical sciences 2001;90(1):38-46.
2001: Wolf B; Rey L C; Moreira L B; Milatovic D; Fleer A; Verhoef J; Roord J J
Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumonia.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2001;5(3):155-9.
2001: Van Der Lubben I M; Konings F A; Borchard G; Verhoef J C; Junginger H E
In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.
Journal of drug targeting 2001;9(1):39-47.
2000: Antal-Szalmás P; Poppelier M J; Broekhuizen R; Verhoef J; van Strijp J A; van Kessel K P
Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Cytometry 2000;41(4):279-88.
2000: Nieuwenhuis E E; Visser M R; Kavelaars A; Cobelens P M; Fleer A; Harmsen W; Verhoef J; Akkermans L M; Heijnen C J
Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.
Arthritis and rheumatism 2000;43(11):2583-9.
2000: Wolf B; Rey L C; Brisse S; Moreira L B; Milatovic D; Fleer A; Roord J J; Verhoef J
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, Brazil.
The Journal of antimicrobial chemotherapy 2000;46(5):757-65.
2000: Schmitz F J; Fluit A C; Hafner D; Beeck A; Perdikouli M; Boos M; Scheuring S; Verhoef J; Köhrer K; Von Eiff C
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Antimicrobial agents and chemotherapy 2000;44(11):3229-31.
2000: Borst A; Leverstein-Van Hall M; Verhoef J; Fluit A
Value of terminal subculture of automated blood cultures in patients with candidaemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(10):803-5.
2000: Wolf B; Kools-Sijmons M; Verduin C; Rey L C; Gama A; Roord J; Verhoef J; van Belkum A
Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(10):759-64.
2000: Boven L A; Middel J; Breij E C; Schotte D; Verhoef J; Soderland C; Nottet H S
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines.
Journal of neurovirology 2000;6(5):382-9.
2000: Brisse S; Milatovic D; Fluit A C; Kusters K; Toelstra A; Verhoef J; Schmitz F J
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
Journal of clinical microbiology 2000;38(10):3636-45.
2000: Veldkamp K E; Heezius H C; Verhoef J; van Strijp J A; van Kessel K P
Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.
Infection and immunity 2000;68(10):5908-13.
2000: Bax R; Mullan N; Verhoef J
The millennium bugs--the need for and development of new antibacterials.
International journal of antimicrobial agents 2000;16(1):51-9.
2000: Pereira C F; Boven L A; Middel J; Verhoef J; Nottet H S
Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions.
Journal of leukocyte biology 2000;68(3):423-8.
2000: Bonten M J; Kullberg B J; van Dalen R; Girbes A R; Hoepelman I M; Hustinx W; van der Meer J W; Speelman P; Stobberingh E E; Verbrugh H A; Verhoef J; Zwaveling J H
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy.
The Journal of antimicrobial chemotherapy 2000;46(3):351-62.
2000: de Haas C J; van Leeuwen H J; Verhoef J; van Kessel K P; van Strijp J A
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.
Journal of immunological methods 2000;242(1-2):79-89.
2000: Beaujean D J; Weersink A J; Troelstra A; Verhoef J
A pilot study on infection control in 10 randomly selected European hospitals: results of a questionnaire survey.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2000;21(8):531-4.
2000: Boven L A; Middel J; Verhoef J; De Groot C J; Nottet H S
Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia.
Neuropathology and applied neurobiology 2000;26(4):356-60.
2000: Schmitz F J; Fluit A C; Milatovic D; Verhoef J; Heinz H P; Brisse S
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2000;46(1):109-13.
2000: Thanou M; Verhoef J C; Marbach P; Junginger H E
Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Journal of pharmaceutical sciences 2000;89(7):951-7.
2000: Smits H A; Boven L A; Pereira C F; Verhoef J; Nottet H S
Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia.
European journal of clinical investigation 2000;30(6):526-35.
2000: Schmitz F J; Sadurski R; Verhoef J; Milatovic D; Fluit A C
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics.
The Journal of antimicrobial chemotherapy 2000;45(6):921-3.
2000: Schmitz F J; Sadurski R; Kray A; Boos M; Geisel R; Köhrer K; Verhoef J; Fluit A C
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.
The Journal of antimicrobial chemotherapy 2000;45(6):891-4.
2000: Fluit A C; Verhoef J; Schmitz F J
Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European SENTRY Participants.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(5):370-4.
2000: Vriens M R; Troelstra A; Yzerman E P; Poth A M; Verhoef J; van der Werken C
[Methicillin-resistant Staphylococcus aureus in medical and paramedical personnel returned from work in a foreign hospital]
Nederlands tijdschrift voor geneeskunde 2000;144(19):887-9.
2000: Brisse S; Verduin C M; Milatovic D; Fluit A; Verhoef J; Laevens S; Vandamme P; Tümmler B; Verbrugh H A; van Belkum A
Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.
Journal of clinical microbiology 2000;38(5):1876-84.
2000: Bootsma H J; van Dijk H; Vauterin P; Verhoef J; Mooi F R
Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
Molecular microbiology 2000;36(1):93-104.
2000: de Haas C J; van Leeuwen E M; van Bommel T; Verhoef J; van Kessel K P; van Strijp J A
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
Infection and immunity 2000;68(4):1753-9.
2000: Milatovic D; Schmitz F J; Brisse S; Verhoef J; Fluit A C
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates.
Antimicrobial agents and chemotherapy 2000;44(4):1102-7.
2000: Fluit A C; Jones M E; Schmitz F J; Acar J; Gupta R; Verhoef J
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(3):454-60.
2000: Jones M E; Boenink N M; Verhoef J; Köhrer K; Schmitz F J
Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment.
The Journal of antimicrobial chemotherapy 2000;45(3):353-6.
2000: Fluit A C; Jones M E; Schmitz F J; Acar J; Gupta R; Verhoef J
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997.
Antonie van Leeuwenhoek 2000;77(2):147-52.
2000: Mascini E M; Jansze M; Schellekens J F; Musser J M; Faber J A; Verhoef-Verhage L A; Schouls L; van Leeuwen W J; Verhoef J; van Dijk H
Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
The Journal of infectious diseases 2000;181(2):631-8.
2000: Orendi J M; Nottet H S; De Vos N M; Visser M R; Snippe H; Boucher C A; Verhoef J
Hydroxyurea interferes with antigen-dependent T-cell activation in vitro.
European journal of clinical investigation 2000;30(2):162-6.
2000: Thanou M M; Kotzé A F; Scharringhausen T; Luessen H L; de Boer A G; Verhoef J C; Junginger H E
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
Journal of controlled release : official journal of the Controlled Release Society 2000;64(1-3):15-25.
2000: Thanou M; Florea B I; Langemeÿer M W; Verhoef J C; Junginger H E
N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Pharmaceutical research 2000;17(1):27-31.
2000: Brisse S; Milatovic D; Fluit A C; Verhoef J; Schmitz F J
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(1):64-8.
2000: Diekema D J; Pfaller M A; Turnidge J; Verhoef J; Bell J; Fluit A C; Doern G V; Jones R N;
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.
Microbial drug resistance (Larchmont, N.Y.) 2000;6(3):213-21.
1999: Ballemans C A; Weersink A J; Blok H E; Vandenbroucke-Grauls C M; Verhoef J
Screening for methicillin-resistant Staphylococcus aureus (MRSA): one hour versus twenty-four hours sampling interval.
The Journal of hospital infection 1999;43(4):316-7.
1999: Verhoef J; Gupta R
Surveillance of resistance against antimicrobial agents: a European perspective.
The Journal of hospital infection 1999;43 Suppl():S93-6.
1999: Schmitz F J; Sadurski R; Stattfeld A; Kray A; Verhoef J; Fluit A C
Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin.
The Journal of antimicrobial chemotherapy 1999;44(6):847-9.
1999: Schmitz F J; Fluit A C; Brisse S; Verhoef J; Köhrer K; Milatovic D
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.
FEMS immunology and medical microbiology 1999;26(3-4):281-7.
1999: Mascini E M; Jansze M; Verhoef J; van Dijk H
Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.
Clinical and diagnostic laboratory immunology 1999;6(6):977-80.
1999: Mascini E M; Jansze M; Schouls L M; Fluit A C; Verhoef J; van Dijk H
Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B.
Journal of clinical microbiology 1999;37(11):3469-74.
1999: Junginger H E; Hoogstraate J A; Verhoef J C
Recent advances in buccal drug delivery and absorption--in vitro and in vivo studies.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):149-59.
1999: Widjojoatmodjo M N; Borst A; Schukkink R A; Box A T; Tacken N M; Van Gemen B; Verhoef J; Top B; Fluit A C
Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species.
Journal of microbiological methods 1999;38(1-2):81-90.
1999: Brisse S; Fluit A C; Wagner U; Heisig P; Milatovic D; Verhoef J; Scheuring S; Köhrer K; Schmitz F J
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
Antimicrobial agents and chemotherapy 1999;43(10):2513-6.
1999: Wolf B; Gama A; Rey L; Fonseca W; Roord J; Fleer A; Verhoef J
Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old.
Annals of tropical paediatrics 1999;19(3):287-92.
1999: Pfaller M A; Jones R N; Doern G V; Fluit A C; Verhoef J; Sader H S; Messer S A; Houston A; Coffman S; Hollis R J
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: Schmitz F J; Verhoef J; Fluit A C
Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group.
International journal of antimicrobial agents 1999;12(4):311-7.
1999: Odland B A; Jones R N; Verhoef J; Fluit A; Beach M L
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe).
Diagnostic microbiology and infectious disease 1999;34(4):315-20.
1999: Bootsma H J; Aerts P C; Posthuma G; Harmsen T; Verhoef J; van Dijk H; Mooi F R
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?
Journal of bacteriology 1999;181(16):5090-3.
1999: Brisse S; Milatovic D; Fluit A C; Verhoef J; Martin N; Scheuring S; Köhrer K; Schmitz F J
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.
Antimicrobial agents and chemotherapy 1999;43(8):2051-5.
1999: Thanou M M; Verhoef J C; Romeijn S G; Nagelkerke J F; Merkus F W; Junginger H E
Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea.
International journal of pharmaceutics 1999;185(1):73-82.
1999: van der Bruggen T; Nijenhuis S; van Raaij E; Verhoef J; van Asbeck B S
Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway.
Infection and immunity 1999;67(8):3824-9.
1999: Schmitz F J; Krey A; Geisel R; Verhoef J; Heinz H P; Fluit A C
Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):528-30.
1999: Verhoef J; Beaujean D; Blok H; Baars A; Meyler A; van der Werken C; Weersink A
A Dutch approach to methicillin-resistant Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):461-6.
1999: Beaujean D J; Weersink A J; Blok H E; Frénay H M; Verhoef J
Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital.
The Journal of hospital infection 1999;42(3):213-8.
1999: Verhoef J; Acar J F; Gupta R; Jones R
Surveillance of resistance against antimicrobial agents.
International journal of antimicrobial agents 1999;12(2):77-9.
1999: Schmitz F J; Verhoef J; Fluit A C
Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):450-3.
1999: Schmitz F J; Verhoef J; Fluit A C
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):414-21.
1999: Jones M E; Schmitz F J; Fluit A C; Acar J; Gupta R; Verhoef J
Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):403-8.
1999: Boven L A; Middel J; Portegies P; Verhoef J; Jansen G H; Nottet H S
Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex.
Journal of neuroimmunology 1999;97(1-2):154-62.
1999: Schmitz F J; Verhoef J; Fluit A C
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
The Journal of antimicrobial chemotherapy 1999;43(6):783-92.
1999: Geerlings S E; Brouwer E C; Gaastra W; Verhoef J; Hoepelman A I
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals.
Journal of medical microbiology 1999;48(6):535-9.
1999: de Haas C J; van der Zee R; Benaissa-Trouw B; van Kessel K P; Verhoef J; van Strijp J A
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.
Infection and immunity 1999;67(6):2790-6.
1999: Kotzé A F; Thanou M M; Luessen H L; de Boer B G; Verhoef J C; Junginger H E
Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(3):269-74.
1999: Verhoef J; Snippe H; Nottet H S
Christiaan Eijkman. First bacteriologist at Utrecht University, Nobel laureate for his work on vitamins.
Antonie van Leeuwenhoek 1999;75(3):165-9.
1999: Van Muiswinkel F L; Raupp S F; de Vos N M; Smits H A; Verhoef J; Eikelenboom P; Nottet H S
The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.
Journal of neuroimmunology 1999;96(1):121-30.
1999: Boven L A; Gomes L; Hery C; Gray F; Verhoef J; Portegies P; Tardieu M; Nottet H S
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4319-27.
1999: Troelstra A; de Graaf-Miltenburg L A; van Bommel T; Verhoef J; Van Kessel K P; Van Strijp J A
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4220-5.
1999: van Loo I H; van der Heide H G; Nagelkerke N J; Verhoef J; Mooi F R
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population.
The Journal of infectious diseases 1999;179(4):915-23.
1999: Schmitz F J; Verhoef J; Fluit A
Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitals. SENTRY Participants Group.
The Journal of antimicrobial chemotherapy 1999;43(3):431-4.
1999: Martinez-Freijo P; Fluit A C; Schmitz F J; Verhoef J; Jones M E
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe.
Antimicrobial agents and chemotherapy 1999;43(3):686-9.
1999: Schmitz F J; Fluit A C; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz H P; Jones M E
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1999;43(2):253-9.
1999: Marttin E; Verhoef J C; Spies F; van der Meulen J; Nagelkerke J F; Koerten H K; Merkus F W
The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies.
Journal of controlled release : official journal of the Controlled Release Society 1999;57(2):205-13.
1999: Kotzé A F; Thanou M M; Luebetaen H L; de Boer A G; Verhoef J C; Junginger H E
Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Journal of pharmaceutical sciences 1999;88(2):253-7.
1999: Jones M E; Visser M R; Klootwijk M; Heisig P; Verhoef J; Schmitz F J
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Antimicrobial agents and chemotherapy 1999;43(2):421-3.
1999: Boek W M; Romeijn S G; Graamans K; Verhoef J C; Merkus F W; Huizing E H
Validation of animal experiments on ciliary function in vitro. II. The influence of absorption enhancers, preservatives and physiologic saline.
Acta oto-laryngologica 1999;119(1):98-101.
1999: Boek W M; Romeijn S G; Graamans K; Verhoef J C; Merkus F W; Huizing E H
Validation of animal experiments on ciliary function in vitro. I. The influence of substances used clinically.
Acta oto-laryngologica 1999;119(1):93-7.
1999: Kotzé A F; Luessen H L; de Boer A G; Verhoef J C; Junginger H E
Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;7(2):145-51.
1999: Fluit A C; Schmitz F J; Jones M E; Acar J; Gupta R; Verhoef J
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 1999;3(3):153-6.
1998: Schmitz F J; Fluit A C; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz H P; Hadding U; Jones M E
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;42(6):807-10.
1998: Martinez-Freijo P; Fluit A C; Schmitz F J; Grek V S; Verhoef J; Jones M E
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.
The Journal of antimicrobial chemotherapy 1998;42(6):689-96.
1998: van Nispen C H; Hoepelman A I; Rozenberg-Arska M; Verhoef J; Purkins L; Willavize S A
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
American journal of surgery 1998;176(6A Suppl):27S-31S.
1998: Orendi J M; Bloem A C; Borleffs J C; Wijnholds F J; de Vos N M; Nottet H S; Visser M R; Snippe H; Verhoef J; Boucher C A
Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
The Journal of infectious diseases 1998;178(5):1279-87.
1998: Schmitz F J; Hertel B; Hofmann B; Scheuring S; Verhoef J; Fluit A C; Heinz H P; Köhrer K; Jones M E
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
The Journal of antimicrobial chemotherapy 1998;42(4):561-3.
1998: Schmitz F J; Lindenlauf E; Hofmann B; Fluit A C; Verhoef J; Heinz H P; Jones M E
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1998;42(4):489-95.
1998: de Haas C J; van der Tol M E; Van Kessel K P; Verhoef J; Van Strijp J A
A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3607-15.
1998: Jansen W T; Gootjes J; Zelle M; Madore D V; Verhoef J; Snippe H; Verheul A F
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Clinical and diagnostic laboratory immunology 1998;5(5):703-10.
1998: Van Wamel W J; Vandenbroucke-Grauls C M; Verhoef J; Fluit A C
The effect of culture conditions on the in-vitro adherence of methicillin-resistant Staphylococcus aureus.
Journal of medical microbiology 1998;47(8):705-9.
1998: Verhoef J
[Optimization of the antibiotics policy in the Netherlands. I. The Foundation Task Force for Antibiotics Policy (SWAB)]
Nederlands tijdschrift voor geneeskunde 1998;142(30):1742.
1998: Jones M E; Jones R N; Sader H; Verhoef J; Acar J
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program.
The Journal of antimicrobial chemotherapy 1998;42(1):119-21.
1998: Schmitz F J; Verhoef J; Hadding U; Heinz H P; Jones M E
Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin.
Journal of medical microbiology 1998;47(6):533-41.
1998: Schmitz F J; Verhoef J; Heinz H P; Jones M E
In-vitro activities of quinupristin/dalfopristin and other anti-staphylococcal agents against methicillin-resistant strains of Staphylococcus aureus isolated over a 16-year period.
The Journal of antimicrobial chemotherapy 1998;41(6):662-4.
1998: Van Wamel W J; van Rossum G; Verhoef J; Vandenbroucke-Grauls C M; Fluit A C
Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis.
FEMS microbiology letters 1998;163(1):1-9.
1998: Schmitz F J; Jones M E; Hofmann B; Hansen B; Scheuring S; Lückefahr M; Fluit A; Verhoef J; Hadding U; Heinz H P; Köhrer K
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
Antimicrobial agents and chemotherapy 1998;42(5):1249-52.
1998: Schmitz F J; Steiert M; Hofmann B; Fluit A C; Verhoef J; Heinz H P; Jones M E
Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):272-4.
1998: Schmitz F J; Hofmann B; Hansen B; Scheuring S; Lückefahr M; Klootwijk M; Verhoef J; Fluit A; Heinz H P; Köhrer K; Jones M E
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(4):481-4.
1998: Schmitz F J; Steiert M; Tichy H V; Hofmann B; Verhoef J; Heinz H P; Köhrer K; Jones M E
Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods.
Journal of medical microbiology 1998;47(4):341-51.
1998: Schmitz F J; Steiert M; Hofmann B; Verhoef J; Hadding U; Heinz H P; Köhrer K
Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.
Journal of medical microbiology 1998;47(4):335-40.
1998: Schmitz F J; Verhoef J; Idel H; Hadding U; Heinz H P; Jones M E
Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital.
The Journal of hospital infection 1998;38(3):237-40.
1998: Schmitz F J; Verhoef J; Fluit A; Heinz H P; Jones M E
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(2):311-3.
1998: De Haas C J; de Vos N M; Visser M R; Snippe H; Verhoef J
Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.
Clinical and experimental immunology 1998;111(2):286-92.
1998: Kotzé A F; Luessen H L; de Leeuw B J; de Boer A G; Verhoef J C; Junginger H E
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Journal of controlled release : official journal of the Controlled Release Society 1998;51(1):35-46.
1998: Marttin E; Verhoef J C; Merkus F W
Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Journal of drug targeting 1998;6(1):17-36.
1997: Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
European journal of clinical investigation 1997;27(12):1044-8.
1997: Been-Tiktak A M; de Haas C J; de Graaf L; Boucher C A; Verhoef J; Borleffs J C; Nottet H S; Schuurman R
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.
The Journal of antimicrobial chemotherapy 1997;40(6):847-53.
1997: Beaujean D J; Blok H E; Weersink A J; Verhoef J
Long-term methicillin-resistant Staphylococcus aureus (MRSA) carriage and tagging of patient records: in Utrecht you're not MRSA-positive for life.
The Journal of hospital infection 1997;37(4):338-9.
1997: Chaka W; Heyderman R; Gangaidzo I; Robertson V; Mason P; Verhoef J; Verheul A; Hoepelman A I
Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group.
The Journal of infectious diseases 1997;176(6):1633-6.
1997: Schmitz F J; Veldkamp K E; Van Kessel K P; Verhoef J; Van Strijp J A
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.
The Journal of infectious diseases 1997;176(6):1531-7.
1997: Hustinx W N; Benaissa-Trouw B J; Harmsen T; Klein S; Verhoef J; Hoepelman A I; Kraaijeveld K
Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models.
The Journal of antimicrobial chemotherapy 1997;40(4):567-72.
1997: Hustinx W N; Kraaijeveld K; Hoepelman A I; Verhoef J
Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments.
The Journal of antimicrobial chemotherapy 1997;40(4):475-83.
1997: Veldkamp K E; Van Kessel K P; Verhoef J; Van Strijp J A
Staphylococcal culture supernates stimulate human phagocytes.
Inflammation 1997;21(5):541-51.
1997: Kotzé A F; Luessen H L; de Leeuw B J; de Boer B G; Verhoef J C; Junginger H E
N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Pharmaceutical research 1997;14(9):1197-202.
1997: Schmitz F J; MacKenzie C R; Geisel R; Wagner S; Idel H; Verhoef J; Hadding U; Heinz H P
Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area.
European journal of epidemiology 1997;13(6):709-17.
1997: Schmitz F J; MacKenzie C R; Geisel R; Wagner S; Idel H; Verhoef J; Hadding U; Heinz H P
Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
European journal of epidemiology 1997;13(6):699-708.
1997: Chaka W; Verheul A F; Vaishnav V V; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman A I
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2979-85.
1997: Schmitz F J; Mackenzie C R; Hofmann B; Verhoef J; Finken-Eigen M; Heinz H P; Köhrer K
Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.
Journal of medical microbiology 1997;46(9):773-8.
1997: Beaujean D J; Blok H E; Vandenbroucke-Grauls C M; Weersink A J; Raymakers J A; Verhoef J
Surveillance of nosocomial infections in geriatric patients.
The Journal of hospital infection 1997;36(4):275-84.
1997: Marttin E; Romeijn S G; Verhoef J C; Merkus F W
Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits.
Journal of pharmaceutical sciences 1997;86(7):802-7.
1997: Antal-Szalmas P; Strijp J A; Weersink A J; Verhoef J; Van Kessel K P
Quantitation of surface CD14 on human monocytes and neutrophils.
Journal of leukocyte biology 1997;61(6):721-8.
1997: Jones M E; Peters E; Weersink A M; Fluit A; Verhoef J
Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria.
Lancet 1997;349(9067):1742-3.
1997: Troelstra A; Antal-Szalmas P; de Graaf-Miltenburg L A; Weersink A J; Verhoef J; Van Kessel K P; Van Strijp J A
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
Infection and immunity 1997;65(6):2272-7.
1997: Marttin E; Verhoef J C; Cullander C; Romeijn S G; Nagelkerke J F; Merkus F W
Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Pharmaceutical research 1997;14(5):631-7.
1997: Craane-Van Hinsberg I W; Verhoef J C; Spies F; Bouwstra J A; Gooris G S; Junginger H E; Boddé H E
Electroperturbation of the human skin barrier in vitro: II. Effects on stratum corneum lipid ordering and ultrastructure.
Microscopy research and technique 1997;37(3):200-13.
1997: Romeijn S G; Marttin E; Verhoef J C; Merkus F W
Simplified solid-phase extraction method for determination of dihydroergotamine in rabbit and human serum using high-performance liquid chromatography with fluorescence detection.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):227-32.
1997: Orendi J M; Verheul A F; De Vos N M; Visser M R; Snippe H; Cherniak R; Vaishnav V V; Rijkers G T; Verhoef J
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication.
Clinical and experimental immunology 1997;107(2):293-9.
1997: Troelstra A; Giepmans B N; Van Kessel K P; Lichenstein H S; Verhoef J; Van Strijp J A
Dual effects of soluble CD14 on LPS priming of neutrophils.
Journal of leukocyte biology 1997;61(2):173-8.
1997: Bornemann M A; Verhoef J; Peterson P K
Macrophages, cytokines, and HIV.
The Journal of laboratory and clinical medicine 1997;129(1):10-6.
1997: Nottet H S; Moelans I I; de Vos N M; de Graaf L; Visser M R; Verhoef J
N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-kappaB DNA binding activity.
Journal of leukocyte biology 1997;61(1):33-9.
1997: Chaka W; Verheul A F; Vaishnav V V; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman I M
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
Infection and immunity 1997;65(1):272-8.
1997: Mascini E M; Hazenberg M M; van Dalen A; Verhoef-Verhage L A; van Leeuwen N J; Verhoef J; van Dijk H
Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
Advances in experimental medicine and biology 1997;418():921-2.
1996: Van Embden J D; Van Soolingen D; Heersma H F; De Neeling A J; Jones M E; Steiert M; Grek V; Mooi F R; Verhoef J
Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci.
The Journal of antimicrobial chemotherapy 1996;38(5):905-7.
1996: Luessen H L; de Leeuw B J; Langemeÿer M W; de Boer A B; Verhoef J C; Junginger H E
Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Pharmaceutical research 1996;13(11):1668-72.
1996: Mascini E M; Hazenberg M A; Verhage L A; Holm S E; Verhoef J; van Dijk H
A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant.
Clinical and diagnostic laboratory immunology 1996;3(6):779-81.
1996: Mattsson E; Van Dijk H; Verhoef J; Norrby R; Rollof J
Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes.
Infection and immunity 1996;64(10):4351-5.
1996: Hol C; Schalén C; Verduin C M; Van Dijke E E; Verhoef J; Fleer A; Van Dijk H
Moraxella catarrhalis in acute laryngitis: infection or colonization?
The Journal of infectious diseases 1996;174(3):636-8.
1996: Verhoef J; Hustinx W M; Frasa H; Hoepelman A I
Issues in the adjunct therapy of severe sepsis.
The Journal of antimicrobial chemotherapy 1996;38(2):167-82.
1996: Hoogstraate A J; Verhoef J C; Tuk B; Pijpers A; van Leengoed L A; Verheijden J H; Junginger H E; Boddé H E
In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs.
Journal of pharmaceutical sciences 1996;85(5):457-60.
1996: Frasa H; Benaissa-Trouw B; Tavares L; van Kessel K; Hustinx W; Schellekens J; Kraaijeveld K; Verhoef J
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
Antimicrobial agents and chemotherapy 1996;40(4):999-1004.
1996: Bootsma H J; van Dijk H; Verhoef J; Fleer A; Mooi F R
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
Antimicrobial agents and chemotherapy 1996;40(4):966-72.
1996: Frasa H; Benaissa-Trouw B; Tavares L; van Kessel K; Poppelier M; Kraaijeveld K; Verhoef J
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.
Infection and immunity 1996;64(3):775-81.
1996: Frénay H M; Bunschoten A E; Schouls L M; van Leeuwen W J; Vandenbroucke-Grauls C M; Verhoef J; Mooi F R
Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(1):60-4.
1996: Mattsson E; Van Dijk H; Van Kessel K; Verhoef J; Fleer A; Rollof J
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar.
The Journal of infectious diseases 1996;173(1):212-8.
1995: AlonsoDeVelasco E; Verheul A F; Verhoef J; Snippe H
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
Microbiological reviews 1995;59(4):591-603.
1995: Chaka W; Scharringa J; Verheul A F; Verhoef J; Van Strijp A G; Hoepelman I M
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.
Clinical and diagnostic laboratory immunology 1995;2(6):753-9.
1995: Craane-van Hinsberg W H; Verhoef J C; Bax L J; Junginger H E; Boddé H E
Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.
Pharmaceutical research 1995;12(10):1506-12.
1995: Widjojoatmodjo M N; Fluit A C; Verhoef J
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene.
Journal of clinical microbiology 1995;33(10):2601-6.
1995: Luessen H L; Verhoef J C; Borchard G; Lehr C M; de Boer A G; Junginger H E
Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin.
Pharmaceutical research 1995;12(9):1293-8.
1995: Alonso De Velasco E; Dekker B A; Verheul A F; Feldman R G; Verhoef J; Snippe H
Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.
The Journal of infectious diseases 1995;172(2):562-5.
1995: Pikaar J C; Voorhout W F; van Golde L M; Verhoef J; Van Strijp J A; van Iwaarden J F
Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.
The Journal of infectious diseases 1995;172(2):481-9.
1995: Marttin E; Verhoef J C; Romeijn S G; Merkus F W
Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity.
Pharmaceutical research 1995;12(8):1151-7.
1995: Van Wamel W J; Fluit A C; Wadström T; van Dijk H; Verhoef J; Vandenbroucke-Grauls C M
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus.
Journal of clinical microbiology 1995;33(7):1769-74.
1995: Watson D A; Musher D M; Verhoef J
Pneumococcal virulence factors and host immune responses to them.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(6):479-90.
1995: Hol C; Verduin C M; Van Dijke E E; Verhoef J; Fleer A; van Dijk H
Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.
FEMS immunology and medical microbiology 1995;11(3):207-11.
1995: Verduin C M; Hol C; Van Dijke E; Faber J A; Jansze M; Verhoef J; Van Dijk H
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.
Clinical and diagnostic laboratory immunology 1995;2(3):365-8.
1995: Fluit A C; Widjojoatmodjo M N; Verhoef J
Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR.
Journal of clinical microbiology 1995;33(4):1046-7.
1995: Schipper N G; Verhoef J C; Romeijn S G; Merkus F W
Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Calcified tissue international 1995;56(4):280-2.
1995: Verhoef J; Mattsson E
The role of cytokines in gram-positive bacterial shock.
Trends in microbiology 1995;3(4):136-40.
1995: de Velasco E A; Merkus D; Anderton S; Verheul A F; Lizzio E F; Van der Zee R; Van Eden W; Hoffman T; Verhoef J; Snippe H
Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
Infection and immunity 1995;63(3):961-8.
1995: Benne C A; Kraaijeveld C A; van Strijp J A; Brouwer E; Harmsen M; Verhoef J; van Golde L M; van Iwaarden J F
Interactions of surfactant protein A with influenza A viruses: binding and neutralization.
The Journal of infectious diseases 1995;171(2):335-41.
1995: Vanderbroucke-Grauls C M; Teeuw K B; Ballemans K; Lavooij C; Cornelisse P B; Verhoef J
Bacterial and viral removal efficiency, heat and moisture exchange properties of four filtration devices.
The Journal of hospital infection 1995;29(1):45-56.
1995: Van Kessel K P; Weersink A J; Van der Tol M E; Verhoef J
Stimulated human neutrophils release intact BPI without a concomitant change in expression on the cell surface.
Progress in clinical and biological research 1995;392():305-15.
1994: Nottet H S; van Asbeck B S; de Graaf L; de Vos N M; Visser M R; Verhoef J
Role for oxygen radicals in self-sustained HIV-1 replication in monocyte-derived macrophages: enhanced HIV-1 replication by N-acetyl-L-cysteine.
Journal of leukocyte biology 1994;56(6):702-7.
1994: Hol C; Van Dijke E E; Verduin C M; Verhoef J; van Dijk H
Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.
The Journal of infectious diseases 1994;170(6):1613-6.
1994: Widjojoatmodjo M N; Fluit A C; Verhoef J
Rapid identification of bacteria by PCR-single-strand conformation polymorphism.
Journal of clinical microbiology 1994;32(12):3002-7.
1994: Weersink A J; Van Kessel K P; Van der Tol M E; Verhoef J
Modulation of lipopolysaccharide binding to human granulocytes.
Immunology 1994;83(4):617-23.
1994: DeVelasco E A; Dekker H A; Antal P; Jalink K P; van Strijp J A; Verheul A F; Verhoef J; Snippe H
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.
Vaccine 1994;12(15):1419-22.
1994: Wolfhagen M J; Meijer K; Fluit A C; Torensma R; Bruinsma R A; Fleer A; Verhoef J
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.
Gut 1994;35(11):1608-12.
1994: Van Iwaarden J F; Pikaar J C; Storm J; Brouwer E; Verhoef J; Oosting R S; van Golde L M; van Strijp J A
Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides.
The Biochemical journal 1994;303 ( Pt 2)():407-11.
1994: Teeuw K B; Vandenbroucke-Grauls C M; Verhoef J
Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildings.
Archives of internal medicine 1994;154(20):2339-45.
1994: Schneeberger P M; van Langevelde P; van Kessel K P; Vandenbroucke-Grauls C M; Verhoef J
Lipopolysaccharide induces hyperadhesion of endothelial cells for neutrophils leading to damage.
Shock (Augusta, Ga.) 1994;2(4):296-300.
1994: Mattsson E; Rollof J; Verhoef J; Van Dijk H; Fleer A
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.
Infection and immunity 1994;62(9):3837-43.
1994: Craane-van Hinsberg W H; Bax L; Flinterman N H; Verhoef J; Junginger H E; Boddé H E
Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance.
Pharmaceutical research 1994;11(9):1296-300.
1994: Frénay H M; Peerbooms P G; van Leeuwen W J; Wynne H J; Verhoef J; Hendriks W D; Cools H J
Nursing homes: not a source of methicillin-resistant Staphylococcus aureus in The Netherlands.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):213-4.
1994: Torensma R; Fluit A C; Verhoef J
Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):11-4.
1994: Wolfhagen M J; Fluit A C; Torensma R; Poppelier M J; Verhoef J
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay.
Journal of clinical microbiology 1994;32(7):1629-33.
1994: Orendi J M; Nottet H S; Visser M R; Verheul A F; Snippe H; Verhoef J
Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumour necrosis factor-independent.
AIDS (London, England) 1994;8(4):423-9.
1994: Frénay H M; Theelen J P; Schouls L M; Vandenbroucke-Grauls C M; Verhoef J; van Leeuwen W J; Mooi F R
Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism.
Journal of clinical microbiology 1994;32(3):846-7.
1994: Weersink A J; Rozenberg-Arska M; Westerhof P W; Verhoef J
Rothia dentocariosa endocarditis complicated by an abdominal aneurysm.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(3):489-90.
1994: Alonso de Velasco E; Verheul A F; van Steijn A M; Dekker H A; Feldman R G; Fernández I M; Kamerling J P; Vliegenthart J F; Verhoef J; Snippe H
Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Infection and immunity 1994;62(3):799-808.
1994: Verduin C M; Jansze M; Hol C; Mollnes T E; Verhoef J; van Dijk H
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.
Infection and immunity 1994;62(2):589-95.
1994: de Fijter C W; Oe L P; Nauta J J; van der Meulen J; Verbrugh H A; Verhoef J; Donker A J
Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis.
Annals of internal medicine 1994;120(4):264-71.
1994: Nottet H S; Oteman M H; Visser M R; Verhoef J
Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
The Journal of antimicrobial chemotherapy 1994;33(2):366-8.
1994: Wolfhagen M J; Torensma R; Fluit A C; Aarsman C J; Jansze M; Verhoef J
Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors.
Toxicon : official journal of the International Society on Toxinology 1994;32(1):129-32.
1994: Kuenen J D; van Dijke E E; Hol C; Bootsma H J; Verhoef J; van Dijk H
Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice.
FEMS immunology and medical microbiology 1994;8(1):69-75.
1994: Schipper N G; Romeijn S G; Verhoef J; Merkus F W
Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
Calcified tissue international 1994;54(1):50-5.
1994: Wolfhagen M J; Torensma R; Fluit A C; Verhoef J
Toxins A and B of Clostridium difficile.
FEMS microbiology reviews 1994;13(1):59-64.
1994: De Graaf-Miltenburg L A; Van Vliet K E; Ten Hagen T L; Verhoef J; Van Strijp J A
The role of HSV-induced Fc- and C3b (i)-receptors in bacterial adherence.
Journal of medical microbiology 1994;40(1):48-54.
1994: Hoogstraate A J; Cullander C; Nagelkerke J F; Senel S; Verhoef J C; Junginger H E; Boddé H E
Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium.
Pharmaceutical research 1994;11(1):83-9.
1994: de Fijter C W; Verbrugh H A; Oe P L; Heezius E C; Verhoef J; Donker A J
Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(2):156-62.
1994: Floor M; van Akkeren F; Rozenberg-Arska M; Visser M; Kolsters A; Beumer H; Verhoef J
Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.
Scandinavian journal of infectious diseases 1994;26(2):191-7.
1994: Brulez H F; Heezius E C; de Fijter C W; Oe L P; Verhoef J; Verbrugh H A
In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1994;10():241-4.
1994: van de Wiel B A; Bakker L J; de Graaf L; de Weger R A; Verhoef J; van den Tweel J G; Joling P
Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells.
Advances in experimental medicine and biology 1994;355():159-63.
1993: Schipper N G; Verhoef J C; De Lannoy L M; Romeijn S G; Brakkee J H; Wiegant V M; Gispen W H; Merkus F W
Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
British journal of pharmacology 1993;110(4):1335-40.
1993: Verhoef J; Verhage E A; Visser M R
A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(6):1047-54.
1993: van der Feltz M; Nottet H S; Visser M R; Borleffs J C; Verhoef J
Non-radioactive PCR method for quantification of HIV-infected peripheral blood mononuclear cells in HIV-positive subjects.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(12):961-4.
1993: Frasa H; Procee J; Torensma R; Verbruggen A; Algra A; Rozenberg-Arska M; Kraaijeveld K; Verhoef J
Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.
Journal of clinical microbiology 1993;31(12):3174-8.
1993: Alonso de Velasco E; Verheul A F; Veeneman G H; Gomes L J; van Boom J H; Verhoef J; Snippe H
Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Vaccine 1993;11(14):1429-36.
1993: Watson D A; Musher D M; Jacobson J W; Verhoef J
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(5):913-24.
1993: Verhoef J
Prevention of infections in the neutropenic patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17 Suppl 2():S359-67.
1993: Hoepelman A I; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie S H; Riddell J; Varghese G; Meunier F
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
The Journal of antimicrobial chemotherapy 1993;32 Suppl B():175-86.
1993: Kieft H; Hoepelman A I; Knupp C A; van Dijk A; Branger J M; Struyvenberg A; Verhoef J
Pharmacokinetics of cefepime in patients with the sepsis syndrome.
The Journal of antimicrobial chemotherapy 1993;32 Suppl B():117-22.
1993: Timmerman C P; Mattsson E; Martinez-Martinez L; De Graaf L; Van Strijp J A; Verbrugh H A; Verhoef J; Fleer A
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.
Infection and immunity 1993;61(10):4167-72.
1993: Mattsson E; Verhage L; Rollof J; Fleer A; Verhoef J; van Dijk H
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6.
FEMS immunology and medical microbiology 1993;7(3):281-7.
1993: Kieft H; Hoepelman A I; Zhou W; Rozenberg-Arska M; Struyvenberg A; Verhoef J
The sepsis syndrome in a Dutch university hospital. Clinical observations.
Archives of internal medicine 1993;153(19):2241-7.
1993: Widjojoatmodjo M N; Fluit A C; Torensma R; Verhoef J
Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations.
Journal of immunological methods 1993;165(1):11-9.
1993: Martínez-Martínez L; Timmerman C P; Fleer A; Verhoef J
Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis.
Journal of medical microbiology 1993;39(3):196-203.
1993: Raponi G; Keller N; Rozenberg-Arska M; Lun M T; Mancini C; Verhoef J
Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity.
Infection and immunity 1993;61(9):3976-80.
1993: Corrales I; Weersink A J; Verhoef J; van Kessel K P
Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
Immunology 1993;80(1):84-9.
1993: Cornelissen J J; Maassen K; van Emst L; Weers P M; Harmsen M; Benaissa-Trouw B J; Oosterlaken T A; Kraaijeveld C A; Verhoef J
Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Immunology 1993;79(4):673-80.
1993: Torensma R; Visser M J; Aarsman C J; Poppelier M J; Fluit A C; Verhoef J
Monoclonal antibodies that react with live Listeria spp.
Applied and environmental microbiology 1993;59(8):2713-6.
1993: Wolfhagen M J; Fluit A C; Torensma R; Jansze M; Kuypers A F; Verhage E A; Verhoef J
Comparison of typing methods for Clostridium difficile isolates.
Journal of clinical microbiology 1993;31(8):2208-11.
1993: Nottet H S; de Graaf L; de Vos N M; Bakker L J; van Strijp J A; Visser M R; Verhoef J
Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1993;168(1):84-91.
1993: Hoepelman A I; Sips A P; van Helmond J L; van Barneveld P W; Neve A J; Zwinkels M; Rozenberg-Arska M; Verhoef J
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 1993;31 Suppl E():147-52.
1993: Wolfhagen M J; Fluit A C; Jansze M; Rademaker C M; Verhoef J
Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(6):463-6.
1993: Teeuw K B; Vandenbroucke-Grauls C M; Verhoef J
[Microorganisms in the air and the sick-building syndrome]
Nederlands tijdschrift voor geneeskunde 1993;137(23):1132-5.
1993: Fluit A C; Widjojoatmodjo M N; Box A T; Torensma R; Verhoef J
Rapid detection of salmonellae in poultry with the magnetic immuno-polymerase chain reaction assay.
Applied and environmental microbiology 1993;59(5):1342-6.
1993: Fluit A C; Torensma R; Visser M J; Aarsman C J; Poppelier M J; Keller B H; Klapwijk P; Verhoef J
Detection of Listeria monocytogenes in cheese with the magnetic immuno-polymerase chain reaction assay.
Applied and environmental microbiology 1993;59(5):1289-93.
1993: Nottet H S; Janse I; de Graaf L; Bakker L J; Visser M R; Verhoef J
Infection of epithelial cell line HEp-2 with human immunodeficiency virus type 1 is CD4 dependent.
Journal of medical virology 1993;40(1):39-43.
1993: Hoepelman I M; Havinga W H; Benne R A; Zwinkels M; de Wit M A; de Hond H A; Boon T A; Visser M R; van Asbeck F W; Verhoef J
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(5):343-7.
1993: Schipper N G; Romeijn S G; Verhoef J C; Merkus F W
Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Pharmaceutical research 1993;10(5):682-6.
1993: Hol C; Verduin C M; van Dijke E; Verhoef J; van Dijk H
Complement resistance in Branhamella (Moraxella) catarrhalis.
Lancet 1993;341(8855):1281.
1993: de Fijter C W; Verbrugh H A; Oe L P; Heezius E; Donker A J; Verhoef J; Gokal R
Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(4):411-8.
1993: Cornelissen J J; Mäkel I; Algra A; Benaissa-Trouw B J; Schellekens J F; Kraaijeveld C A; Verhoef J
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.
The Journal of infectious diseases 1993;167(4):876-81.
1993: Nottet H S; de Graaf L; Machiel de Vos N; Bakker L J; van Strijp J A; Visser M R; Verhoef J
Down-regulation of human immunodeficiency virus type (HIV-1) production after stimulation of monocyte-derived macrophages infected with HIV-1.
The Journal of infectious diseases 1993;167(4):810-7.
1993: Visser M R; Beumer H; Hoepelman A I; Rozenberg-Arska M; Verhoef J
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Antimicrobial agents and chemotherapy 1993;37(4):885-8.
1993: Vandenbroucke-Grauls C M; Baars A C; Visser M R; Hulstaert P F; Verhoef J
An outbreak of Serratia marcescens traced to a contaminated bronchoscope.
The Journal of hospital infection 1993;23(4):263-70.
1993: Rademaker C M; Fluit A C; Jausze M; Rozenberg-Arska M; Glerum J H; Verhoef J
Enterovirulent Escherichia coli can cause bacteraemia in immunocompromised patients.
The Journal of infection 1993;26(2):226-8.
1993: Vandenbroucke-Grauls C M; Verhoef J
[A new chapter in the history of tuberculosis]
Nederlands tijdschrift voor geneeskunde 1993;137(13):642-5.
1993: Senel S; Hoogstraate A J; Spies F; Verhoef J C; Junginger H E; Boddé H E
Visualization of enhancing effects of bile salts on buccal penetration.
European journal of morphology 1993;31(1-2):35-41.
1993: Rademaker C M; Fluit A C; Jansze M; Jansen W H; Glerum J H; Verhoef J
Frequency of enterovirulent Escherichia coli in diarrhoeal disease in The Netherlands.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(2):93-7.
1993: de Fijter C W; Verbrugh H A; Peters E D; Oe P L; van der Meulen J; Verhoef J; Donker A J
In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
Clinical nephrology 1993;39(2):75-80.
1993: Rademaker C M; Martinez-Martinez L; Perea E J; Jansze M; Fluit A C; Glerum J H; Verhoef J
Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes.
Journal of medical microbiology 1993;38(2):87-9.
1993: Joling P; Bakker L J; Van Strijp J A; Meerloo T; de Graaf L; Dekker M E; Goudsmit J; Verhoef J; Schuurman H J
Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1065-73.
1993: Verduin C M; Hol C; Bootsma H J; Verhoef J; van Dijk H
Observations on constitutional resistance to infection.
Immunology today 1993;14(1):44-5.
1993: Van Vliet K E; De Graaf-Miltenburg L A; Verhoef J; Van Strijp J A
A flow cytometric rosetting assay for the analysis of Fc receptors and C3 receptors on HSV-infected cells.
Journal of immunological methods 1993;157(1-2):57-64.
1993: Fluit A C; Wolfhagen M J; Jansze M; Torensma R; Verhoef J
Comment to Knoop et al. (1990) FEBS Letters 267, 9-12, toxin B of Clostridium difficile does not have enolase activity.
FEBS letters 1993;316(1):103-5.
1993: Verheul A F; Van Gaans J A; Wiertz E J; Snippe H; Verhoef J; Poolman J T
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
Infection and immunity 1993;61(1):187-96.
1993: Weersink A J; van Kessel K P; van den Tol M E; van Strijp J A; Torensma R; Verhoef J; Elsbach P; Weiss J
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):253-63.
1993: Joling P; Bakker L J; van Wichen D F; de Graaf L; Meerloo T; Visser M R; van Strijp J A; Goudsmit J; Verhoef J; Schuurman H J
Binding of HIV-1 to human follicular dendritic cells.
Advances in experimental medicine and biology 1993;329():455-60.
1993: Nicolle L E; Hoepelman A I; Floor M; Verhoef J; Norgard K
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.
Scandinavian journal of infectious diseases 1993;25(5):631-7.
1992: Rademaker C M; Rozenberg-Arska M; Fluit A C; Wolfhagen M J; Glerum J H; Verhoef J
[Detection of diarrhea-causing Escherichia coli using DNA-probes]
Nederlands tijdschrift voor geneeskunde 1992;136(52):2581-4.
1992: Torensma R; Visser M J; Aarsman C J; Poppelier M J; van Beurden R; Fluit A C; Verhoef J
Monoclonal antibodies that detect live salmonellae.
Applied and environmental microbiology 1992;58(12):3868-72.
1992: Widjojoatmodjo M N; Fluit A C; Torensma R; Verdonk G P; Verhoef J
The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples.
Journal of clinical microbiology 1992;30(12):3195-9.
1992: van Iwaarden J F; van Strijp J A; Visser H; Haagsman H P; Verhoef J; van Golde L M
Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.
The Journal of biological chemistry 1992;267(35):25039-43.
1992: Frénay H M; Vandenbroucke-Grauls C M; Molkenboer M J; Verhoef J
Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital.
The Journal of hospital infection 1992;22(3):207-15.
1992: Kovarik J M; Hoepelman A I; Smit J M; Sips P A; Rozenberg-Arska M; Glerum J H; Verhoef J
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Antimicrobial agents and chemotherapy 1992;36(11):2458-61.
1992: Visser M R; Bogaards L; Rozenberg-Arska M; Verhoef J
Comparison of the autoSCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(11):979-84.
1992: Nottet H S; Janse I; De Vos N M; Bakker L J; Visser M R; Verhoef J
Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.
European journal of clinical investigation 1992;22(10):670-5.
1992: de Fijter C W; Verbrugh H A; Oe L P; Peters E D; van der Meulen J; Donker A J; Verhoef J
Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.
Kidney international 1992;42(4):947-50.
1992: Hoepelman I M; Verhoef J
[New macrolides, azalides and streptogramins; current role and their future perspective]
Nederlands tijdschrift voor geneeskunde 1992;136(38):1847-51.
1992: Van Vliet K E; De Graaf-Miltenburg L A; Verhoef J; Van Strijp J A
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.
Immunology 1992;77(1):109-15.
1992: Verhoef J; Gekker G; Erice A; Peterson P K; Balfour H H
Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(8):715-21.
1992: Lehr C M; Bouwstra J A; Kok W; De Boer A G; Tukker J J; Verhoef J C; Breimer D D; Junginger H E
Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat.
The Journal of pharmacy and pharmacology 1992;44(5):402-7.
1992: Cornelissen J J; de Graeff A; Verdonck L F; Branger T; Rozenberg-Arska M; Verhoef J; Dekker A W
Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.
Antimicrobial agents and chemotherapy 1992;36(4):801-7.
1992: Hofland H E; Bouwstra J A; Verhoef J C; Buckton G; Chowdry B Z; Ponec M; Junginger H E
Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants.
The Journal of pharmacy and pharmacology 1992;44(4):287-94.
1992: Timmerman C; Hoepelman I; de Hond J; Boon T; Schreinemachers L; Mensink H; Verhoef J
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections.
Infection 1992;20(1):34-7.
1992: Bakker L J; Nottet H S; de Vos N M; de Graaf L; Van Strijp J A; Visser M R; Verhoef J
Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes.
AIDS (London, England) 1992;6(1):35-41.
1992: Oosting R S; Van Iwaarden J F; Van Bree L; Verhoef J; Van Golde L M; Haagsman H P
Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells.
The American journal of physiology 1992;262(1 Pt 1):L63-8.
1992: Ferguson D A; Veringa E M; Mayberry W R; Overbeek B P; Lambe D W; Verhoef J
Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes.
Microbios 1992;69(278):53-65.
1992: de Fijter C W; Biemond A; Oe L P; Moesker H L; Verhoef J; Donker A J; Verbrugh H A
Pharmacokinetics of ciprofloxacin after intraperitoneal administration in uninfected patients undergoing CCPD.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1992;8():18-21.
1991: van Kessel K P; van Strijp J A; Verhoef J
Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(11):3862-8.
1991: Widjojoatmodjo M N; Fluit A C; Torensma R; Keller B H; Verhoef J
Evaluation of the magnetic immuno PCR assay for rapid detection of Salmonella.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(11):935-8.
1991: Fluit A C; Wolfhagen M J; Verdonk G P; Jansze M; Torensma R; Verhoef J
Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B.
Journal of clinical microbiology 1991;29(11):2666-7.
1991: Verheul A F; Poolman J T; Snippe H; Verhoef J
The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies.
Molecular immunology 1991;28(11):1193-200.
1991: Timmerman C P; Fleer A; Besnier J M; De Graaf L; Cremers F; Verhoef J
Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene.
Infection and immunity 1991;59(11):4187-92.
1991: Verheul A F; Boons G J; Van der Marel G A; Van Boom J H; Jennings H J; Snippe H; Verhoef J; Hoogerhout P; Poolman J T
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.
Infection and immunity 1991;59(10):3566-73.
1991: Merkus F W; Verhoef J C; Romeijn S G; Schipper N G
Interspecies differences in the nasal absorption of insulin.
Pharmaceutical research 1991;8(10):1343.
1991: Cornelissen J J; Schellekens J F; Kraaijeveld C A; Verhoef J
Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
The Netherlands journal of medicine 1991;39(3-4):170-6.
1991: Vogelpoel F R; van Kooij R J; te Velde E R; Verhoef J
Influence of polymorphonuclear granulocytes on the zona-free hamster oocyte assay.
Human reproduction (Oxford, England) 1991;6(8):1104-7.
1991: Timmerman C P; Besnier J M; De Graaf L; Torensma R; Verkley A J; Fleer A; Verhoef J
Characterisation and functional aspects of monoclonal antibodies specific for surface proteins of coagulase-negative staphylococci.
Journal of medical microbiology 1991;35(2):65-71.
1991: Oosting R S; van Greevenbroek M M; Verhoef J; van Golde L M; Haagsman H P
Structural and functional changes of surfactant protein A induced by ozone.
The American journal of physiology 1991;261(2 Pt 1):L77-83.
1991: Rademaker C M; Krul M R; Jansen W H; Vos N M; Hoepelman I M; Rozenberg-Arska M; Verhoef J
Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(8):625-9.
1991: van Iwaarden J F; van Strijp J A; Ebskamp M J; Welmers A C; Verhoef J; van Golde L M
Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages.
The American journal of physiology 1991;261(2 Pt 1):L204-9.
1991: Oosting R S; van Golde L M; Verhoef J; Van Bree L
Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures.
Toxicology and applied pharmacology 1991;110(1):170-8.
1991: Schipper N G; Verhoef J C; Merkus F W
The nasal mucociliary clearance: relevance to nasal drug delivery.
Pharmaceutical research 1991;8(7):807-14.
1991: Torensma R; van Wijk A; Visser M J; Bouter A; Rozenberg-Arska M; Verhoef J
Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli.
Journal of clinical microbiology 1991;29(7):1356-8.
1991: Muijsken M A; Heezius H J; Verhoef J; Verbrugh H A
Role of mesothelial cells in peritoneal antibacterial defence.
Journal of clinical pathology 1991;44(7):600-4.
1991: Verhoef J
Selective decontamination of the intestines: an important clinical treatment modality?
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(6):477-8.
1991: Merkus F W; Verhoef J C; Romeijn S G; Schipper N G
Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
Pharmaceutical research 1991;8(5):588-92.
1991: Visser M R; Rozenberg-Arska M; Beumer H; Hoepelman I M; Verhoef J
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
Antimicrobial agents and chemotherapy 1991;35(5):858-68.
1991: van Strijp J A; van der Tol M E; Miltenburg L A; van Kessel K P; Verhoef J
Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.
Immunology 1991;73(1):77-82.
1991: Cornelissen J J; Van Kessel C P; Brouwer E; Kraaijeveld C A; Verhoef J
Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin.
Journal of medical microbiology 1991;34(4):233-8.
1991: Weersink A; Visser M; Vos A; Hulstaert P; ten Berge I; Muijsken M; van Vroonhoven T; Verhoef J
Amoxicillin-clavulanate prophylaxis against wound infections after clean-contaminated surgery. A controlled, randomized, prospective study.
The European journal of surgery = Acta chirurgica 1991;157(4):271-5.
1991: Rozenberg-Arska M; Dekker A W; Branger J; Verhoef J
A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.
The Journal of antimicrobial chemotherapy 1991;27(3):369-76.
1991: Verheul A F; Braat A K; Leenhouts J M; Hoogerhout P; Poolman J T; Snippe H; Verhoef J
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.
Infection and immunity 1991;59(3):843-51.
1991: Verhoef J
The phagocytic process and the role of complement in host defense.
Journal of chemotherapy (Florence, Italy) 1991;3 Suppl 1():93-7.
1991: Verhoef J
Host-pathogen relationships in respiratory tract infections.
Clinical therapeutics 1991;13(1):172-80.
1991: van Bree J B; van Nispen J W; Verhoef J C; Breimer D D
Development of specific antisera against 9-desglycinamide-8-arginine vasopressin by site-specific immunization.
Journal of pharmaceutical sciences 1991;80(1):46-9.
1991: Vandenbroucke-Grauls C M; Frénay H M; van Klingeren B; Savelkoul T F; Verhoef J
Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(1):6-11.
1991: Ligtenberg P C; Hoepelman I M; Oude Sogtoen G A; Dekker A W; van der Tweel I; Rozenberg-Arska M; Verhoef J
C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(1):25-31.
1991: Keller N; Raponi G; Hoepelman I M; Overbeek B P; Rozenberg-Arska M; Verhoef J
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1991;274(4):519-26.
1991: Raponi G; Keller N; Overbeek B P; Rozenberg-Arska M; Torensma R; Verhoef J
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
The Journal of infectious diseases 1991;163(1):122-7.
1991: de Vries M E; Boddé H E; Verhoef J C; Junginger H E
Developments in buccal drug delivery.
Critical reviews in therapeutic drug carrier systems 1991;8(3):271-303.
1991: Rozenberg-Arska M; Dekker A W; Verhoef J
Prevention of infections in granulocytopenic patients by fluorinated quinolones.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1991;121():337-46.
1991: de Fijter C W; Verbrugh H A; Oe P L; Peters E D; van der Meulen J; Donker A J; Verhoef J; Lameire N
The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1991;7():154-7.
1991: de Fijter C W; Verbrugh H A; Peters E D; Oe P L; van der Meulen J; Donker A J; Verhoef J
Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1991;7():150-3.
1990: Kovarik J M; de Hond J A; Hoepelman I M; Boon T; Verhoef J
Intraprostatic distribution of lomefloxacin following multiple-dose administration.
Antimicrobial agents and chemotherapy 1990;34(12):2398-401.
1990: Rademaker C M; Sips A P; Beumer H M; Hoepelman I M; Overbeek B P; Möllers M J; Rozenberg-Arska M; Verhoef J
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
The Journal of antimicrobial chemotherapy 1990;26 Suppl D():75-81.
1990: Verhoef J
Transient immunodepression.
The Journal of antimicrobial chemotherapy 1990;26 Suppl C():23-9.
1990: Kovarik J M; ter Maaten J C; Rademaker C M; Deenstra M; Hoepelman I M; Hart H C; Matzke G R; Verhoef J
Pharmacokinetics of cefepime in patients with respiratory tract infections.
Antimicrobial agents and chemotherapy 1990;34(10):1885-8.
1990: Fleer A; Timmerman C P; Besnier J M; Pascual A; Verhoef J
Surface proteins of coagulase-negative staphylococci: their role in adherence to biomaterials and in opsonization.
Journal of biomaterials applications 1990;5(2):154-65.
1990: de Fijter C W; Verbrugh H A; Heezius H C; van der Meulen J; Oe P L; Donker A J; Verhoef J
Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.
The Journal of antimicrobial chemotherapy 1990;26(4):525-32.
1990: van Kessel K P; van Strijp J A; van Kats-Renaud H J; Miltenburg L A; Fluit A C; Verhoef J
Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient.
Journal of leukocyte biology 1990;48(4):359-66.
1990: Fluit A C; Box A T; Verhoef J
A probe for the detection of methicillin-resistant Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(8):605-8.
1990: Oosting R S; van Bree L; van Iwaarden J F; van Golde L M; Verhoef J
Impairment of phagocytic functions of alveolar macrophages by hydrogen peroxide.
The American journal of physiology 1990;259(2 Pt 1):L87-94.
1990: Weersink A J; Van Kessel K P; Torensma R; Van Strijp J A; Verhoef J
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):318-24.
1990: Frénay H M; Vandenbroucke-Grauls C M; Savelkoul T J; Rommes J H; van Klingeren B; Verhoef J
[Spread and control of a methicillin-resistant Staphylococcus aureus in an academic hospital]
Nederlands tijdschrift voor geneeskunde 1990;134(24):1169-73.
1990: Vandenbroucke-Grauls C M; Verhoef J
[The control of methicillin-resistant Staphylococcus aureus; worthwhile?]
Nederlands tijdschrift voor geneeskunde 1990;134(24):1163-5.
1990: van der Wal N A; van Oirschot J F; van Dijk A; Verhoef J; van Asbeck B S
Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine.
Biochemical pharmacology 1990;39(11):1665-71.
1990: Cornelissen J J; Oosterlaken T A; Schellekens J; Torensma R; Rozenberg-Arska M; Kraaijeveld C A; Verhoef J
Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A.
Journal of immunological methods 1990;130(1):141-7.
1990: Hermens W A; Deurloo M J; Romeyn S G; Verhoef J C; Merkus F W
Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Pharmaceutical research 1990;7(5):500-3.
1990: Goossens H; Pot B; Vlaes L; Van den Borre C; Van den Abbeele R; Van Naelten C; Levy J; Cogniau H; Marbehant P; Verhoef J
Characterization and description of "Campylobacter upsaliensis" isolated from human feces.
Journal of clinical microbiology 1990;28(5):1039-46.
1990: Geelen S P; Fleer A; Bezemer A C; Gerards L J; Rijkers G T; Verhoef J
Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
Pediatric research 1990;27(5):514-8.
1990: Van Strijp J A; Miltenburg L A; van der Tol M E; Van Kessel K P; Fluit A C; Verhoef J
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.
The Journal of general virology 1990;71 ( Pt 5)():1205-9.
1990: Vogelpoel F R; Van Kooij R J; Te Velde E R; Verhoef J
Influence of complement on sperm motility.
International journal of andrology 1990;13(2):81-6.
1990: Verhoef J; Torensma R
Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(4):247-50.
1990: van Bree J B; Tio S; de Boer A G; Danhof M; Verhoef J C; Breimer D D
Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology.
Pharmaceutical research 1990;7(3):293-8.
1990: Wolfhagen M J; Hoepelman I M; Verhoef J
[Urinary tract infection in the elderly; what does it mean?]
Nederlands tijdschrift voor geneeskunde 1990;134(10):470-3.
1990: Wolfhagen M J; Hoepelman A I; Verhoef J
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections.
Antimicrobial agents and chemotherapy 1990;34(3):409-12.
1990: de Jongh-Leuvenink J; Schellekens J; Verhoef J
Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.
Infection and immunity 1990;58(2):421-6.
1990: Haagen I A; Heezius H C; Verkooyen R P; Verhoef J; Verbrugh H A
Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers.
The Journal of infectious diseases 1990;161(2):266-73.
1990: Raponi G; Keller N; Overbeek B P; Rozenberg-Arska M; van Kessel K P; Verhoef J
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.
Antimicrobial agents and chemotherapy 1990;34(2):332-6.
1990: van Hoogdalem E J; Heijligers-Feijen C D; Verhoef J C; de Boer A G; Breimer D D
Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
Pharmaceutical research 1990;7(2):180-3.
1990: van Iwaarden F; Welmers B; Verhoef J; Haagsman H P; van Golde L M
Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.
American journal of respiratory cell and molecular biology 1990;2(1):91-8.
1990: Hoepelman I M; Bezemer W A; Vandenbroucke-Grauls C M; Marx J J; Verhoef J
Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes.
Infection and immunity 1990;58(1):26-31.
1990: Kovarik J; Rozenberg-Arska M; Visser M; Verhoef J
Pharmacodynamics of cefepime.
Scandinavian journal of infectious diseases. Supplementum 1990;74():270-3.
1990: van Bronswijk H; Verbrugh H A; Heezius E C; Verkooyen R P; van der Meulen J; Verhoef J
Host defence in CAPD treatment: the effect of the dialysate on cell function.
Contributions to nephrology 1990;85():67-72.
1989: Visser M R; Hoepelman I M; Beumer H; Rozenberg-Arska M; Verhoef J
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(12):1061-4.
1989: Erich T; Schellekens J; Bouter A; Van Kranen J; Brouwer E; Verhoef J
Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(12):4053-60.
1989: Rademaker C M; Jones R W; Notarianni L J; van Dijk A; Glerum J H; Verhoef J
Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models.
Pharmaceutisch weekblad. Scientific edition 1989;11(6):224-8.
1989: Fluit A C; van Strijp J A; Miltenburg L A; van Kessel C P; Snippe H; Verhoef J
The use of a hybridization assay for the study of host defences against herpes simplex virus.
Journal of virological methods 1989;26(3):269-78.
1989: van Hoogdalem E J; Heijligers-Feijen C D; Mathôt R A; Wackwitz A T; van Bree J B; Verhoef J C; de Boer A G; Breimer D D
Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
The Journal of pharmacology and experimental therapeutics 1989;251(2):741-4.
1989: van Kessel K P; van Strijp J A; van der Tol M E; van Kats-Renaud H J; Thijssen R M; Fluit A C; Verhoef J
Quantitation of conjugate formation between human polymorphonuclear leukocytes and antibody-coated target cells by flow cytometry: the role of Fc receptor and LFA-1 antigen.
Journal of leukocyte biology 1989;46(5):467-75.
1989: Verhoef J; Rozenberg-Arska M; Dekker A
Prevention of infection in the neutropenic patient.
Reviews of infectious diseases 1989;11 Suppl 7():S1545-50.
1989: Deurloo M J; Hermens W A; Romeyn S G; Verhoef J C; Merkus F W
Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Pharmaceutical research 1989;6(10):853-6.
1989: Bodde H E; Verhoef J C; Ponec M
Transdermal peptide delivery.
Biochemical Society transactions 1989;17(5):943-5.
1989: Verhoef J; Rozenberg-Arska M; Dekker A W
Prevention of bacterial and fungal infections in granulocytopenic patients.
European journal of cancer & clinical oncology 1989;25(9):1345-50.
1989: Veringa E M; Ferguson D A; Lambe D W; Verhoef J
Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1989;271(3):311-20.
1989: Kovarik J M; Hoepelman I M; Verhoef J
Once-daily aminoglycoside administration: new strategies for an old drug.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(9):761-9.
1989: Hoepelman I M; Bezemer W A; van Doornmalen E; Verhoef J; Marx J J
Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes.
British journal of haematology 1989;72(4):584-8.
1989: Rademaker C M; Hoepelman I M; Wolfhagen M J; Beumer H; Rozenberg-Arska M; Verhoef J
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(8):690-4.
1989: Rozenberg-Arska M; Dekker A; Verdonck L; Verhoef J
Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.
Infection 1989;17(4):240-4.
1989: Rozenberg-Arska M; Dekker A W; Verhoef J
Prevention of infections in granulocytopenic patients by fluorinated quinolones.
Reviews of infectious diseases 1989;11 Suppl 5():S1231-6.
1989: Vandenbroucke-Grauls C M; Thijssen H M; Tetteroo P A; Rozemuller E; Verhoef J
Increased expression of leucocyte adherence-related glycoproteins by polymorphonuclear leucocytes during phagocytosis of staphylococci on an endothelial surface.
Scandinavian journal of immunology 1989;30(1):91-8.
1989: Van Strijp J A; Van Kessel K P; van der Tol M E; Verhoef J
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.
The Journal of clinical investigation 1989;84(1):107-12.
1989: van Bree J B; de Boer A G; Verhoef J C; Danhof M; Breimer D D
Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
The Journal of pharmacology and experimental therapeutics 1989;249(3):901-5.
1989: van Bronswijk H; Verbrugh H A; Heezius H C; Renders N H; Fleer A; van der Meulen J; Oe P L; Verhoef J
Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
Immunology 1989;67(1):81-6.
1989: Kovarik J M; Hoepelman I M; Verhoef J
Influence of fluoroquinolones on expression and function of P fimbriae in uropathogenic Escherichia coli.
Antimicrobial agents and chemotherapy 1989;33(5):684-8.
1989: Veringa E M; Ferguson D A; Lambe D W; Verhoef J
The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin.
The Journal of antimicrobial chemotherapy 1989;23(5):711-20.
1989: Veringa E M; Lambe D W; Ferguson D A; Verhoef J
Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.
The Journal of antimicrobial chemotherapy 1989;23(4):577-87.
1989: Raponi G; Vreede R W; Rozenberg-Arska M; Hoepelman I M; Keller N; Verhoef J
The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.
The Journal of antimicrobial chemotherapy 1989;23(4):565-76.
1989: Van Kessel K P; Van Strijp J A; Miltenburg L M; Van Kats-Renaud H J; Fluit A C; Verhoef J
Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes.
Journal of immunological methods 1989;118(2):279-85.
1989: Erich T; Dekker B; De Beer M; Torensma R; Verhoef J
In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas.
Journal of immunological methods 1989;118(1):17-24.
1989: Hoepelman I M; Rozenberg-Arska M; Verhoef J
[Monotherapy or combination therapy in severe bacterial infections?]
Nederlands tijdschrift voor geneeskunde 1989;133(6):284-6.
1989: van Hoogdalem E J; Heijligers-Feijen C D; de Boer A G; Verhoef J C; Breimer D D
Rectal absorption enhancement of des-enkephalin-gamma-endorphin (DE gamma E) by medium-chain glycerides and EDTA in conscious rats.
Pharmaceutical research 1989;6(1):91-5.
1989: Raponi G; Keller N; Rozenberg-Arska M; Hoepelman I M; Verhoef J
The influence of cefepime on opsonophagocytosis of bacteria.
Drugs under experimental and clinical research 1989;15(4):141-4.
1989: de Fijter C W; Verbrugh H A; Heezius H C; van Bronswijk H; van der Meulen J; Oe P L; Donker A J; Verhoef J
Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1989;5():124-7.
1989: Van Strijp J A; Van Kessel K P; van der Tol M E; Fluit A C; Snippe H; Verhoef J
Phagocytosis of herpes simplex virus by human granulocytes and monocytes.
Archives of virology 1989;104(3-4):287-98.
1989: van Bronswijk H; Verbrugh H A; Bos H J; Heezius E C; Oe P L; van der Meulen J; Verhoef J
Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1989;9(3):197-202.
1989: Fleer A; Verhoef J
An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 1989;2(4):391-6.
1988: Hoepelman I M; Jaarsma E Y; Verhoef J; Marx J J
Effect of iron on polymorphonuclear granulocyte phagocytic capacity: role of oxidation state and effect of ascorbic acid.
British journal of haematology 1988;70(4):495-500.
1988: Kerver A J; Rommes J H; Mevissen-Verhage E A; Hulstaert P F; Vos A; Verhoef J; Wittebol P
Prevention of colonization and infection in critically ill patients: a prospective randomized study.
Critical care medicine 1988;16(11):1087-93.
1988: Vandenbroucke-Grauls C M; Kerver A J; Rommes J H; Jansen R; den Dekker C; Verhoef J
Endemic Acinetobacter anitratus in a surgical intensive care unit: mechanical ventilators as reservoir.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(4):485-9.
1988: Calandra T; Glauser M P; Schellekens J; Verhoef J
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
The Journal of infectious diseases 1988;158(2):312-9.
1988: van Bronswijk H; Verbrugh H A; Heezius H C; van der Meulen J; Oe P L; Verhoef J
Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(3):368-73.
1988: Hoepelman I M; Rozenberg-Arska M; Verhoef J
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections.
Lancet 1988;1(8598):1305-9.
1988: van Bree J B; de Boer A G; Danhof M; Verhoef J C; van Wimersma Greidanus T B; Breimer D D
Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat.
Peptides 1988;9(3):555-9.
1988: Hoepelman A I; Bakker L J; Verhoef J
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Antimicrobial agents and chemotherapy 1988;32(4):473-6.
1988: Pascual A; Fleer A; Westerdaal N A; Berghuis M; Verhoef J
Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(2):161-6.
1988: Hoepelman I M; Jaarsma E Y; Verhoef J; Marx J J
Polynuclear iron complexes impair the function of polymorphonuclear granulocytes.
British journal of haematology 1988;68(3):385-9.
1988: van Strijp J A; van Kessel K P; Miltenburg L A; Fluit A C; Verhoef J
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.
Journal of virology 1988;62(3):847-50.
1988: Wolfhagen M J; Hoepelman I M; de Melker R A; Verhoef J
[Diagnosis of uncomplicated urinary tract infections: complicated?]
Nederlands tijdschrift voor geneeskunde 1988;132(9):390-4.
1988: Fleer A; Gerards L J; Verhoef J
Host defence to bacterial infection in the neonate.
The Journal of hospital infection 1988;11 Suppl A():320-7.
1988: Veringa E; Box A; Rozenberg-Arska M; Verhoef J
Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Drugs under experimental and clinical research 1988;14(1):1-8.
1988: Fleer A; Roord J J; Neeleman C; Timmerman H; Verhoef J; Stoop J W
Metabolic activation of human polymorphonuclear leukocytes by opsonized Haemophilus influenzae type b.
Acta paediatrica Hungarica 1988;29(1-2):131-5.
1988: Hoepelman I M; Rozenberg-Arska M; Verhoef J
Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora.
Chemotherapy 1988;34 Suppl 1():21-9.
1988: Vandenbroucke-Grauls C M; Verhoef J
Bacteria, phagocytes, and bystander cells. Interaction between Staphylococcus aureus, polymorphonuclear leukocytes, and endothelial cells.
Pathology and immunopathology research 1988;7(3):149-61.
1987: Van Kessel K P; Van Strijp J A; Van Kats-Renaud H J; Miltenburg L A; Van Der Tol M E; Fluit A C; Verhoef J
Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
Immunology 1987;62(4):675-8.
1987: Vlaspolder F; de Zeeuw G; Rozenberg-Arska M; Egyedi P; Verhoef J
The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract.
Infection 1987;15(4):241-4.
1987: Vandenbroucke-Grauls C M; Thijssen H M; van Kessel K P; van Asbeck B S; Verhoef J
Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products.
Infection and immunity 1987;55(6):1447-54.
1987: Vandenbroucke-Grauls C M; Thijssen H M; Verhoef J
Opsonization of Staphylococcus aureus protects endothelial cells from damage by phagocytosing polymorphonuclear leukocytes.
Infection and immunity 1987;55(6):1455-60.
1987: Overbeek B P; Schellekens J F; Lippe W; Dekker B A; Verhoef J
Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5.
Journal of clinical microbiology 1987;25(6):1009-13.
1987: Ward K N; Fleer A; Verhoef J; Jones D M
Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains.
Journal of clinical pathology 1987;40(4):361-7.
1987: Verbrugh H A; van Bronswijk H; van der Meulen J; Oe P L; Verhoef J
Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.
Contributions to nephrology 1987;57():85-91.
1987: Kerver A J; Rommes J H; Mevissen-Verhage E A; Hulstaert P F; Vos A; Verhoef J; Wittebol P
Colonization and infection in surgical intensive care patients--a prospective study.
Intensive care medicine 1987;13(5):347-51.
1987: Veringa E M; Verhoef J
Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
Chemotherapy 1987;33(4):243-9.
1987: Hoepelman I M; Steyger G; Rozenberg-Arska M; Verhoef J
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics.
Chemotherapy 1987;33(2):103-9.
1987: Hoepelman I M; Verhoef J
Antimicrobial agents and opsonic defence.
Annali dell'Istituto superiore di sanità 1987;23(4):921-3.
1987: Vogelpoel F R; te Velde E R; Scheenjes E; Van Kooy R; Kremer J; Verhoef J
Antibody and complement-binding activity of viable and nonviable human spermatozoa.
Archives of andrology 1987;18(3):189-97.
1986: Veringa E M; Verhoef J
Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process.
Antimicrobial agents and chemotherapy 1986;30(5):796-7.
1986: Hoepelman I M; Verhoef J
[Chemotherapeutic agents and antibiotics in urinary tract infections]
Nederlands tijdschrift voor geneeskunde 1986;130(40):1788-90.
1986: Pascual A; Fleer A; Westerdaal N A; Verhoef J
Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro.
European journal of clinical microbiology 1986;5(5):518-22.
1986: Rozenberg-Arska M; Porsius J C; Jaarsma E Y; Verhoef J
Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
Journal of medical microbiology 1986;22(2):143-9.
1986: Fleer A; Verhoef J; Pascual Hernandez A
Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity.
The American journal of medicine 1986;80(6B):161-5.
1986: Vreede R W; Marcelis J H; Verhoef J
Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
Infection and immunity 1986;52(3):892-6.
1986: Henricks P A; Verhoef J; Nijkamp F P
Modulation of phagocytic cell function.
Veterinary research communications 1986;10(3):165-88.
1986: Vreede R W; Leuvenink J; Bouter A S; Brouwer E C; Marcelis J H; Verhoef J
Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
European journal of clinical microbiology 1986;5(2):141-7.
1986: Van Kessel K P; Van Kats-Renaud H J; Van Strijp J A; Visser M R; Verhoef J
Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
Journal of immunological methods 1986;88(1):101-7.
1986: de Jongh-Leuvenink J; Bouter A S; Marcelis J H; Schellekens J; Verhoef J
Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
European journal of clinical microbiology 1986;5(2):148-51.
1986: Henricks P A; van der Tol M E; Engels F; Nijkamp F P; Verhoef J
Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis of Staphylococcus aureus.
Inflammation 1986;10(1):37-47.
1986: Henricks P A; van der Tol M; Verhoef J
Production of leukotriene B4 by polymorphonuclear leukocytes during phagocytosis of Staphylococcus aureus.
Agents and actions 1986;17(3-4):388-9.
1985: Henricks P A; van der Tol M E; Verhoef J
Interactions between human polymorphonuclear leukocytes and influenza virus.
Scandinavian journal of immunology 1985;22(6):721-5.
1985: Rozenberg-Arska M; Van Asbeck B S; Martens T F; Verhoef J
Damage to chromosomal and plasmid DNA by toxic oxygen species.
Journal of general microbiology 1985;131(12):3325-30.
1985: Mevissen-Verhage E A; Marcelis J H; Guinée P A; Verhoef J
Effect of iron on serotypes and haemagglutination patterns of Escherichia coli in bottle-fed infants.
European journal of clinical microbiology 1985;4(6):570-4.
1985: Rozenberg-Arska M; Salters M E; van Strijp J A; Geuze J J; Verhoef J
Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes.
Infection and immunity 1985;50(3):852-9.
1985: de Jongh-Leuvenink J; Vreede R W; Marcelis J H; de Vos M; Verhoef J
Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
Infection and immunity 1985;50(3):716-20.
1985: Fleer A; Gerards L J; Aerts P; Westerdaal N A; Senders R C; van Dijk H; Verhoef J
Opsonic defense to Staphylococcus epidermidis in the premature neonate.
The Journal of infectious diseases 1985;152(5):930-7.
1985: Vandenbroucke-Grauls C M; Thijssen H M; Verhoef J
Phagocytosis of staphylococci by human polymorphonuclear leukocytes is enhanced in the presence of endothelial cells.
Infection and immunity 1985;50(1):250-4.
1985: Kalter E S; Jaspers F C; van Dijk W C; Nijkamp F P; de Jong W; Verhoef J
Induction of the early hypotensive phase by Escherichia coli: role of bacterial surface structures and inflammatory mediators.
The Journal of infectious diseases 1985;152(3):493-9.
1985: Rozenberg-Arska M; Dekker A W; Verhoef J
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
The Journal of infectious diseases 1985;152(1):104-7.
1985: Mevissen-Verhage E A; Marcelis J H; Harmsen-Van Amerongen W C; de Vos N M; Verhoef J
Effect of iron on neonatal gut flora during the first three months of life.
European journal of clinical microbiology 1985;4(3):273-8.
1985: Kalter E S; Daha M R; ten Cate J W; Verhoef J; Bouma B N
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
The Journal of infectious diseases 1985;151(6):1019-27.
1985: Overbeek B P; Rozenberg-Arska M; Verhoef J
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.
European journal of clinical microbiology 1985;4(2):140-1.
1985: Verhoef J
[The prescribing of antibiotics]
Nederlands tijdschrift voor geneeskunde 1985;129(13):581-3.
1985: van Velzen-Blad H; Dijkstra Y J; Schurink G A; Verbrugh H A; Verhoef J; Zegers B J; Ballieux R E
Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis.
The Annals of thoracic surgery 1985;39(3):207-11.
1985: Vreede R W; Verhoef J
[The interaction between food, nutritional status, metabolism and orally administered antimicrobial agents]
Nederlands tijdschrift voor geneeskunde 1985;129(2):55-8.
1985: Overbeek B P; Rozenberg-Arska M; Verhoef J
Do quinolones really augment the antifungal effect of amphotericin B in vitro?
Drugs under experimental and clinical research 1985;11(11):745-6.
1984: Henricks P A; Van der Tol M E; Van Kats-Renaud J H; Nijkamp F P; Verhoef J
Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte function.
Biochimica et biophysica acta 1984;801(2):206-14.
1984: Henricks P A; van der Tol M E; Verhoef J
Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria.
Immunology 1984;52(4):671-8.
1984: Vandenbroucke-Grauls C M; Thijssen H M; Verhoef J
Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.
Immunology 1984;52(3):427-35.
1984: van Asbeck B S; Marx J J; Struyvenberg A; Verhoef J
Functional defects in phagocytic cells from patients with iron overload.
The Journal of infection 1984;8(3):232-40.
1984: Rozenberg-Arska M; van Strijp J A; Hoekstra W P; Verhoef J
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase.
The Journal of clinical investigation 1984;73(5):1254-62.
1984: van Asbeck B S; Marx J J; Struyvenberg A; van Kats J H; Verhoef J
Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes.
Blood 1984;63(3):714-20.
1984: Vandenbroucke-Grauls C M; Verhoef J
Acquired immune deficiency syndrome in the Netherlands.
European journal of clinical microbiology 1984;3(1):62.
1984: van Asbeck B S; Marx J J; Struyvenberg A; van Kats J H; Verhoef J
Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(2):851-6.
1984: Vandenbroucke-Grauls C M; Thijssen R M; Marcelis J H; Sharma S D; Verhoef J
Effects of lysosomotropic amines on human polymorphonuclear leucocyte function.
Immunology 1984;51(2):319-26.
1984: Rozenberg-Arska M; Salters E C; van Strijp J A; Hoekstra W P; Verhoef J
Degradation of Escherichia coli chromosomal and plasmid DNA in serum.
Journal of general microbiology 1984;130(1):217-22.
1984: Fleer A; Verhoef J
New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens.
Antonie van Leeuwenhoek 1984;50(5-6):729-44.
1984: Schellekens J F; Kalter E S; Vreede R W; Verhoef J
Host-parasite interaction in serious infections due to gram-negative bacteria.
Antonie van Leeuwenhoek 1984;50(5-6):701-10.
1983: Fleer A; Senders R C; Visser M R; Bijlmer R P; Gerards L J; Kraaijeveld C A; Verhoef J
Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis.
Pediatric infectious disease 1983;2(6):426-31.
1983: van Asbeck B S; Marcelis J H; Marx J J; Struyvenberg A; van Kats J H; Verhoef J
Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
European journal of clinical microbiology 1983;2(5):426-31.
1983: Kalter E S; van Dijk W C; Timmerman A; Verhoef J; Bouma B N
Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
The Journal of infectious diseases 1983;148(4):682-91.
1983: van Asbeck B S; Marcelis J H; van Kats J H; Jaarsma E Y; Verhoef J
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
European journal of clinical microbiology 1983;2(5):432-8.
1983: Milatovic D; Braveny I; Verhoef J
Clindamycin enhances opsonization of Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1983;24(3):413-7.
1983: Henricks P A; van der Tol M E; Thyssen R M; van Asbeck B S; Verhoef J
Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes.
Infection and immunity 1983;41(1):294-301.
1983: Rozenberg-Arska M; Dekker A W; Verhoef J
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
Infection 1983;11(3):167-9.
1983: van Asbeck B S; Verhoef J
Iron and host defence.
European journal of clinical microbiology 1983;2(1):6-10.
1983: Verhoef J; Musher D M; Spika J S; Verbrugh H A; Jaspers F C
The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo.
Scandinavian journal of infectious diseases. Supplementum 1983;41():79-86.
1983: Peterson P K; Quie P G; Kim Y; Wilkinson B J; Verbrugh H A; Verhoef J
Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface.
Scandinavian journal of infectious diseases. Supplementum 1983;41():67-78.
1983: Verhoef J; Fleer A
Staphylococcus epidermidis endocarditis and Staphylococcus epidermidis infection in an intensive care unit.
Scandinavian journal of infectious diseases. Supplementum 1983;41():56-64.
1983: Verbrugh H A; Verhoef J; Wilkinson B J; Peterson P K
Biology and clinical significance of peptidoglycan antibody response in staphylococcal infections.
Scandinavian journal of infectious diseases. Supplementum 1983;41():117-25.
1982: Vandenbroucke-Grauls C M; Rozenberg-Arska M; den Hengst C W; Verhoef J
Prostatitis due to penicillinase-producing Neisseria gonorrhoeae. Case reports.
The British journal of venereal diseases 1982;58(5):311-3.
1982: Spika J S; Peterson P K; Wilkinson B J; Hammerschmidt D E; Verbrugh H A; Verhoef J; Quie P G
Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.
The Journal of infectious diseases 1982;146(2):227-34.
1982: Henricks P A; van Erne-van der Tol M E; Verhoef J
Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(2):745-50.
1982: van Dijk W C; Verbrugh H A; van Rijswijk R E; Vos A; Verhoef J
Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients.
Surgery 1982;92(1):21-9.
1982: Debets-Ossenkopp Y; Mills E L; van Dijk W C; Verbrugh H A; Verhoef J
Effect of influenza virus on phagocytic cells.
European journal of clinical microbiology 1982;1(3):171-7.
1982: Meshulam T; Verbrugh H A; Verhoef J
Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
European journal of clinical microbiology 1982;1(2):112-7.
1982: van Asbeck B S; Verbrugh H A; van Oost B A; Marx J J; Imhof H W; Verhoef J
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.
British medical journal (Clinical research ed.) 1982;284(6315):542-4.
1982: Verbrugh H A; Hoidal J R; Nguyen B Y; Verhoef J; Quie P G; Peterson P K
Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.
The Journal of clinical investigation 1982;69(1):63-74.
1982: Verhoef J; Mills E L; Debets-Ossenkopp Y; Verbrugh H A
The effect of influenza virus on oxygen-dependent metabolism of human neutrophils.
Advances in experimental medicine and biology 1982;141():647-54.
1981: Spika J S; Verbrugh H A; Verhoef J
Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
Infection and immunity 1981;34(2):455-60.
1981: van Dijk W C; Verbrugh H A; van Erne-van der Tol M E; Peters R; Verhoef J
Escherichia coli antibodies in opsonisation and protection against infection.
Journal of medical microbiology 1981;14(4):381-9.
1981: Dekker A W; Rozenberg-Arska M; Sixma J J; Verhoef J
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
Annals of internal medicine 1981;95(5):555-9.
1981: Verbrugh H A; Peterson P K; Smith D E; Nguyen B Y; Hoidal J R; Wilkinson B J; Verhoef J; Furcht L T
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages.
Infection and immunity 1981;33(3):811-9.
1981: Verbrugh H A; Peters R; Rozenberg-Arska M; Peterson P K; Verhoef J
Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.
The Journal of infectious diseases 1981;144(1):1-9.
1981: Musher D M; Verbrugh H A; Verhoef J
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(1):84-8.
1981: Verhoef J; Verbrugh H A
Host determinants in staphylococcal disease.
Annual review of medicine 1981;32():107-22.
1980: van Dijk W C; Verbrugh H A; van der Tol M E; Peters R; Peterson P K; Quie P G; Verhoef J
Interactions of phagocytic and bacterial cells in patients with bacteremia caused by gram-negative rods.
The Journal of infectious diseases 1980;141(4):441-9.
1980: Verbrugh H A; van Dijk W C; Peters R; van Erne M E; Daha M R; Peterson P K; Verhoef J
Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(3):1167-73.
1980: Debets-Ossenkopp Y; van Dijk W C; Mills E L; Verbrugh H A; Verhoef J
The effect of influenza virus on human polymorphonuclear leukocytes.
Antonie van Leeuwenhoek 1980;46(1):103.
1980: Verbrugh H A; van Dijk W C; Hendrickx G F; van der Stadt D; Stoop J W; Peterson P K; Verhoef J
Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections.
Scandinavian journal of infectious diseases 1980;12(2):111-6.
1979: Verbrugh H A; van Dijk W C; van Erne M E; Peters R; Peterson P K; Verhoef J
Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
Infection and immunity 1979;26(3):808-14.
1979: Schmeling D J; Peterson P K; Hammerschmidt D E; Kim Y; Verhoef J; Wilkinson B J; Quie P G
Chemotaxigenesis by cell surface components of Staphylococcus aureus.
Infection and immunity 1979;26(1):57-63.
1979: Van Dijk W C; Verbrugh H A; van der Tol M E; Peters R; Verhoef J
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
Infection and immunity 1979;25(2):603-9.
1979: Verbrugh H A; Van Dijk W C; Peters R; Van Der Tol M E; Verhoef J
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
Immunology 1979;37(3):615-21.
1979: Verbrugh H A; Van Dijk W C; Peters R; Van Der Tol M E; Peterson P K; Verhoef J
Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Immunology 1979;36(3):391-7.
1979: Van Dijk W C; Verbrugh H A; Peters R; Van Der Tol M E; Peterson P K; Verhoef J
Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
Journal of medical microbiology 1979;12(1):123-30.
1979: Verhoef J; Peterson P K; Verbrugh H A
Host-parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis.
Antonie van Leeuwenhoek 1979;45(1):49-53.
1979: Rozenberg-Arska M; Fabius G T; Beens-Dekkers M A; Duursma S A; Sabath L D; Verhoef J
Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.
Chemotherapy 1979;25(6):352-5.
1979: Williams D N; Peterson P K; Verhoef J; Laverdiere M; Sabath L D
Endocarditis caused by coagulase-negative staphylococci.
Infection 1979;7(1):5-9.
1978: Peterson P K; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie P G
Complement-mediated phagocytosis of Pseudomonas aeruginosa.
The Journal of laboratory and clinical medicine 1978;92(6):883-94.
1978: Verhoef J; Peterson P K; Williams D N; Laverdiere M; Sabath L D
Atrio-ventricular shuntinfections and endocarditis due to Staphylococcus epidermidis.
Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 1978;241(1):95-100.
1978: Verbrugh H A; Peters R; Peterson P K; Verhoef J
Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.
Journal of clinical pathology 1978;31(6):539-45.
1978: Peterson P K; Wilkinson B J; Kim Y; Schmeling D; Douglas S D; Quie P G; Verhoef J
The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
The Journal of clinical investigation 1978;61(3):597-609.
1977: Giebink G S; Verhoef J; Peterson P K; Quie P G
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
Infection and immunity 1977;18(2):291-7.
1977: Peterson P K; Verhoef J; Schmeling D; Quie P G
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.
The Journal of infectious diseases 1977;136(4):502-9.
1977: Verhoef J; Peterson P K; Quie P G
Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.
Immunology 1977;33(2):231-9.
1977: Verhoef J; Peterson P; Kim Y; Sabath L D; Quie P G
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
Immunology 1977;33(2):191-7.
1977: Peterson P K; Verhoef J; Sabath L D; Quie P G
Effect of protein A on staphylococcal opsonization.
Infection and immunity 1977;15(3):760-4.
1977: Peterson P K; Verhoef J; Quie P G
Influence of temperature on opsonization and phagocytosis of staphylococci.
Infection and immunity 1977;15(1):175-9.
1977: Verhoef J; Peterson P K; Quie P G
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.
Journal of immunological methods 1977;14(3-4):303-11.
1976: Peterson P K; Verhoef J; Sabath L D; Quie P G
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.
Infection and immunity 1976;14(2):496-501.
1973: Verhoef J; Oe P L; Simonian S
Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney.
Antonie van Leeuwenhoek 1973;39(4):654.
1973: Verhoef J; Oe P L; Simonian S
The clearance of antibiotics by the artificial kidney.
Chemotherapy 1973;19(5):272-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jan Verhoef

Research Profile (preview)

Living Beings

Physiology

Anatomy

Procedures

Chemicals & Drugs

Disorders

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jan Verhoef (preview)

All Publications